The relationship between obesity, hyperlipoprotheinemy and the form of severity of coronary artery disease, were analised in the patients on Clinic for Cardiovascular diseases University Clinical Center Tuzla. The goal of the research was to determine does obesity with hyperlipoprotheinemy couses the worst form of coronary artery disease. Materials and methods: There were 140 patients (57,88 ± 9,33 years); 77 men and 63 women in randomised study during six months. The patients were divided in two groups: a) experimental group: the patients who were obese by central type of obesity (waist circumference a bove 88 cm in women and 102 cm in men,and b) control group the patients who were not obese by central type of obesity. BMI, WHR ratio, waist circumference, cholesterol, LDL, HDL, tryglicerides were measured in all patients. Coronarography with onewessels disease were easier form of disease, and two and treewessels disease were the worst form of disease. Results: The average waist circumference was 94, 02 ± 4,72 cm. Average BMI was 27,40 ± 5,01, Between all patients, 59 of patients had the worst form of disease, and 81 of the patients had easier form of disease. Statistically important difference were found (P=0,0008, OR=2,84). Between 59 of the patients with the worst for m of disease, 19 of the pati ents had BMI>30, and between 81 patients with easier form of disease 12 of the patients had BMI>30 (P=0,05, OR=2,39).Statistically important difference found in the level of cholesterol (P=0,0012, OR=2,38), the level of LDL (P=0,02, OR=2,38), and HDL cholesterol (P=0,01, OR=2,72). The difference in WHR ratio were statistically important, too (P=0,002).
The metabolic syndrome is a complex and multifactorial disorder often associated with type 2 diabetes and cardiovascular diseases. The liver X receptor alpha (LXRA) plays numerous roles in metabolic pathways involved in metabolic syndrome. In the search for susceptibility genes to metabolic syndrome, we hypothesized that common genetic variation in LXRA gene influences metabolic syndrome susceptibility. Two large French populationbased studies (n=1130 and n=1166) including overall 664 individuals with and 1626 individuals without metabolic syndrome were genotyped for three polymorphisms, accounting for >96% of the genetic variability of LXRA. We found that the rare allele of one of the polymorphisms was consistently associated with a 30% reduction in risk of metabolic syndrome in the two independent population samples (adjusted OR [95% CI]=0.68 [0.53−0.86], P=0.001 in the combined sample). Moreover, it was associated with an increase in plasma HDL-cholesterol concentrations. These results suggest that LXRA plays an important role in the genetic susceptibility to metabolic syndrome, partly explained by its action on HDL metabolism. 1. Conflict of Interest: None Disclosed. 2. Funding. Research relating to this abstract was funded by the Conseil Régional du Nord-Pas de Calais, the CPAM de Sélestat, the Association Régionale de Cardiologie d'Alsace, ONIVINS, Parke -Davis Laboratory, the MGEN, the Réseau Nati onal de Santé Publique, the Direction Générale de la Santé, the INSERM, the Institut Pasteur de Lille, and the Unité d'Evaluation du CHU de Lille. This work was also supported by CRESCENDO, an Integrated Project funding from FP6 (contract n° LSHM - CT-2005-018652 acronym of the project 'Nutrient-Gene interactions in human obesityimplications for dietary guidelines' supported by the European Community (Contract no. QLK1-CT-2000-00618); 4 acronym of the project 'Diet, Obesity and Genes' supported by the European Community (Contract no. FP6-513946) The outcome of hypocaloric diets is highly variable at the individual level. The European programs, NUGENOB and DioGenes focus on gene-nutrient interactions during nutritional weight reducing challenges in obese subjects. The present study aims to characterize biomarkers of dietary intervention using transcriptomic analyses of human adipose tissue(AT). 2 groups of 24 obese women following energy restricted diets with moderate-fat or low fat content for 10 weeks have been selected from a cohort of ~750 obese subjects. The groups are similar regarding changes in weight and metabolic parameters during the diets. Probes made from the subcutaneous AT RNA both before and after dietary restriction period were hybridized to pangenomic microarrays. Different strategies were used to analyze the data. The search for calorie restriction sensitive genes was performed using SAM, a permutation algorithm with multiple testing adjustments which yielded 1800 differential transcripts, the large majority being down regulated as shown on a smaller subset of genes (Viguerie, Diabetologia, 2005) . In order to set up a list of transcripts which changes in expression were different regarding the nutrient composition of the hypocaloric diet, two independent statistical strategies have been tested: PAM, a partitional clustering algorithm and random forest, a trainingvalidation approach. The lists from each method were merged and genes were classified. The 10 top ranking transcripts have been tested using RT-qPCR on an enlarged set of subjects. Investigation of the biological relevance of each putative biomarker will now help to connect energy metabolism, nutrients and gene expression changes under caloric restriction.
T1:PO.11
Differential regulation of adipose tissue inflammation-related genes during very low calorie diet and weight maintenance phase in human obese subjects Capel Frederic 1,2 , Viguerie Nathalie Adipose tissue secretes inflammation-related molecules that may be involved in the modulation of insulin sensitivity. Caloric restriction programs have been shown to improve the adipose tissue inflammatory status of obese subjects. The present work aimed at determining the relationship between the expression profiles of inflammation-related genes and the different phases of a weight loss program. Eight obese women followed 4 weeks of very low calorie diet (VLCD) and 5 to 8 months of a weight maintenance program (WM). Transcriptomic analysis of subcutaneous adipose tissues obtained at baseline, after the VLCD and after WM was performed using pangenomic oligonucleotide microarrays. Among significantly regulated genes, we observed a marked regulation of genes involved in immunity and defense processes in the different phases of the protocol. Variations of the expression levels of these genes were analyzed concomitantly with changes in anthropometric and insulin sensitivity parameters. Insulin sensitivity was improved during VLCD and remained ameliorated after WM. A fraction of inflammatory-related genes were downregulated during VLCD and tended to return to baseline levels during WM. On the contrary, WM regulated the expression of genes which remained unaffected by VLCD. Regulation of these genes could contribute to the long term effect of weight loss on insulin sensitivity. This kinetic analysis during a weight loss program reveals that inflammationrelated genes are differentially regulated by the energy deficit during severe calorie restriction and the new energetic status obtained during a weight maintenance phase. It may help to delineate new biomarkers of insulin resistance in human obesity.
T1:PO.12
Microarray data of human white adipocytes overexpressing PGC-1alpha and regulation of glycerol kinase by PPARalpha Plasma free fatty acids released from white adipose tissue may contribute to the metabolic abnormalities found in obese subjects. Expression of the transcriptional coactivator peroxisome proliferator -activated receptor gamma (PPARgamma) coactivator 1alpha (PGC-1alpha) in human adipocytes leads to a PPARgammadependent induction of the uncoupling protein UCP1 and promotes fat oxidation. Here, pangenomic microarray experiments were performed to get an exhaustive view at changes in gene expression induced by PGC-1alpha. Among the large number of genes regulated by PGC-1alpha independently of PPAR gamma, were new targets involved in metabolism including the gene encoding glycerol kinase (GyK). The induction of GyK by PGC-1alpha was observed at the levels of mRNA and enzymatic activity. PPARalpha was also upregulated by PGC -1alpha. Its activation led to an increase in GyK expression and activity. PPARalpha was shown to bind and activate the GyK promoter in PGC -1alpha expressing human adipocytes. In vivo data in different mouse models confirmed the role of PGC1alpha and PPARalpha in the regulation of GyK. The induction of GyK by PGC1alpha and PPARalpha offers a new strategy to promote fat utilization in fat cells through the generation of a futile cycle between triglyceride hydrolysis and fatty acid reesterification. Moreover, this work uncovers novel pathways regulated by PGC -1alpha and reveals that PPAR alpha controls gene expression in human white adipocytes.
Abstracts

S48
International Journal of Obesity
T1:PO.13
The first intron of the human UCP3 gene governs expression in skeletal muscles in vivo Uncoupling protein-3 (UCP3) is an inner mitochondrial membrane transporter mainly expressed in skeletal muscles in humans and in brown adipose tissue and skeletal muscles in rodents. UCP3 may protect against lipid induced oxidative damages and play a role in fatty acid oxidation. In humans, UCP3 content is higher in fast contracting glycolytic muscles than in slow contracting oxidative muscles. Here, we have studied the molecular mechanisms determining UCP3 expression and characterized the sequences responsible for specific muscular expression. We have created transgenic mice bearing a 16 kb sequence of the human UCP3 gene (hUCP3) including the promoter and all intron-exon sequences. The transgene expression was comparable to that of the endogenous murine UCP3 gene (mUCP3). Further transgenesis experiments with a hUCP3 promoter chloramphenicol acetyl transferase (CAT) gene construct did not result in expression of the reporter gene in mouse tissues. Creation of additional lines with intron 1 linked to the promoter reporter gene construct resulted in an expression profile of the CAT gene in skeletal muscles comparable to that of hUCP3, i.e., higher expression in glycolytic than in oxidative muscles. For instance within intron 1, the 5' 600 bp-long region is the smallest fragment conferring skeletal muscle expression of the transgene. Therefore, hUCP3 expression in skeletal muscles is not solely conferred by the promoter but depends on cis acting elements in intron 1. Studies with cellular models revealed several important regulatory elements in the hUCP3 promoter; however our transgenesis experiments demonstrate the necessity of intron 1 in vivo.
T1:PO.14
The Leu7Pro7 genotype of preproNPY leads to rapid increase in intima media thickness and decreasing vasodilatation responsiveness in over-weight patients with diabetes --two-year preliminary results Centre for Biotechnology, University of Turku Neuropeptide Y (NPY) is a sympathetic transmitter that has various physiological functions. Leucine7 to Proline7 (Leu7Pro) polymorphism of preproNPY is associated with altered sympathetic transmitter concentrations and vascular diseases. Middle-aged men with Leu7Pro7 genotype have enhanced endotheliumdependent flow-mediated endothelial dilatation (FMD). We have monitored the progression of brachial FMD and brachial artery intima-media thickness (bIMT) in patients with type 2 diabetes (T2D). Twelve patients with T2D without diabetic complications having Leu7Pro7 genotype and 19 with Leu7Leu7 genotype attended an annual follow-up including a non-invasive ultrasound assessment of vascular function and structure. To measure FMD, ultrasound scans were taken at rest and after reactive hyperemia induced by a forearm cuff-release. Sublingual glyceryl trinitrate spray (1.2mg) was used to investigate endothelium independent nitrate dependent vasodilatation (NMD). The measurements were repeated after a 2 year follow-up. P-values were obtained by t-test for continuous and Mann-Whitney for skewed variables. Baseline brachial vessel size, FMD, NMD and bIMT were similar between Leu7Pro7 and Leu7Leu7 genotypes. The 2-year increase in bIMT was significantly greater in the Leu7Pro7 genotype than in the Leu7Leu7 genotype (0.07±0.06 vs. 0.03±0.08 mm, P=0.019). In addition, NMD reduced more in the Leu7Pro7 genotype (-1.8±1.7 vs. -0.1±2.6 %, P=0.037). Changes in FMD were similar between the genotypes. However, positive correlation of IL-6 with 2-year change in FMD was found in Leu7Pro7 genotype (P<0.001) and negative correlation in Leu7Leu7 genotype (p=0.040). Patients with T2D and the Leu7Pro7 genotype have more rapid increase in brachial IMT and a decrease in brachial NMD compared to T2D patients with the Leu7Leu7 genotype, suggestive of increased rate of atherosclerosis.
Jaakkola
T1:PO.15
Hypoxia Induces GLUT1, GLUT3 and GLUT5 Facilitative Glucose Transporter Expression (but not GLUT4, GLUT10 and GLUT12) We have recently suggested that hypoxia may occur in enlarged adipocytes distant from the vasculature as adipose tissue mass expands in obesity, and that this leads to changes in the production of inflammation-related adipokines. Hypoxia can induce a range of metabolic adaptations in cells, including the augmentation of glucose utilisation. In initial studies, expression of the GLUT1 facilitative glucose transporter in adipocytes was rapidly increased by hypoxia; we have now examined the effects of low O 2 tension and chemically -induced hypoxia on the expression of other members of the GLUT transporter family expressed by human adipocytes. Human adipocytes (15 days post -differentiation in culture) were exposed to 1% O 2 or 100 •M CoCl2 for up to 24 h, while control cells were maintained in 21% O 2 alone. mRNA levels of the GLUT1, GLUT3, GLUT4, GLUT5, GLUT10 and GLUT12 transporters were quantified by real -time PCR. There was no significant change in the mRNA level of GLUT4, GLUT10 and GLUT12 in response to either 1% O 2 or CoCl2. However, there were substantial increases in GLUT1 (maximum 14-fold), GLUT3 (maximum 10 -fold) and GLUT5 (maximum 9 -fold) mRNAs in response to both low O 2 tension and chemically-induced hypoxia. These increases were particularly rapid for GLUT3, and were accompanied by an elevation in the cellular level of the key hypoxia-sensitive transcription factor, HIF-1•. It is concluded that hypoxia induces rapid increases in the expression of facilitative glucose transporters in human adipocytes, consistent with increased glucose utilisation. The response is, however, selective to specific GLUTs.
T1:PO.16
Neuromedin beta: The polymorphism P73T in Czech obese and nonobese women Adiponutrin is a non-secreted adipose specific protein with triglyceride lipase and transacylase activities, regulated by changes in energy balance (increased expression after re-feeding) in rodents and up-regulated during adipocyte differentiation, that has been proposed to be involved in the maintaining of energy homeostasis. The objective of this work is to characterise the effect of feeding conditions on adiponutrin expression behaviour in different rat adipose tissue depots under normal and obese conditions. Two rat models were used, Wistar (lean and overweight) and Zucker (lean and obese), submitted to fasting/re-feeding. Adiponutrin was determined in different white adipose tissue depots (epididymal, inguinal, mesenteric and retroperitoneal) and in interescapular brown adipose tissue by RT-PCR. We have found site-specific differences in adiponutrin expression in different adipose depots. The depot-specific adiponutrin expression is similar in lean and obese animals, except in the inguinal depot, where adiponutrin is overexpressed in obese Zucker. Independently of the degree of expression in the tissue, adiponutrin is an acute sensor of feeding conditions: in lean rats, 14-h fasting greatly decreases adiponutrin mRNA levels in all the depots studied, while 3-h re-feeding allows the recovery of the levels found in control animals. In both overweight Wistar and obese Zucker rats, the decreased mRNA expression observed after fasting in lean rats is not as evident and, moreover, in the obese Zucker there is no recovery after re-feeding. We can conclude that adiponutrin expression is highly regulated by feeding conditions in the different adipose tissue depots, but this regulation is impaired in obese rats.
T1:PO.18
Oleoyl-estrone inhibits the expression of 17-beta-hydroxysteroid dehydrogenase in rat tissues Adult male overweight rats were treated for 10 days with oral gavages of 10 nmol/g oleoyl-estrone (OE), and compared with controls and pair-fed (PF). Day 10 lumbar WAT, testicles and adrenal gland RNA was used for real-time PCR amplification using primers for 17-beta-hydroxysteroid dehydrogenase isoenzymes 1,2,3,4,7,8 and 11. Testosterone, androstenedione, estradiol and estrone in serum were measured by HPLC-MS/MS. Testosterone and androstenedione levels decreased versus controls in OE (x1/10) and PF (x1/2); estradiol (x2) and estrone increased in OE (x4) and decreased in PF (x1/2). Enzyme expression (compared with controls) in testicle of OE was 70-95%, and PF 80-100%; in adrenals OE was 95-120% and PF 100-144%; in WAT OE was 35-74% and PF 32-82%. The androgen drop seems to be a consequence of lower expression (activity) of the enzyme in testicle and, especially, in WAT, affecting similarly odd and pair isoenzymes (i.e. both directions of the reaction). This limits the conversion to estradiol of excess available estrone (from OE hydrolysis), thus limiting the estrogenic effects. However, this also results in decreased testosterone synthesis. These effects are very close to those observed in PF, receiving no estrone load, which suggest that energy availability may play also a significant role in androgen/estrogen metabolism. Disclosure M.M. Romero and R. Vilà are employees of the University of Barcelona spinoff Oleoyl-Estrone Developments SL, Barcelona, Spain; M. Esteve, J.A. Fernández-López and M. Alemany are shareholders of the same company Financing sources This study was supported by grants PI052179 of the "Fondo de Investigaciones Sanitarias", and BFU2005-00524 of the "Plan Nacional de Investigación en Biología Fundamental", both from the Government of Spain, as well by a research contract of Oleoyl-Estrone Developments SL, (Barcelona, Spain).
T1:PO.19
Beckwith Beckwith-Wiedemann Sindrome (BWS) is a congenital overgrowth syndrome: the incidence is about 1:13700 births, with an equal sex distribution. It's a clinically and genetically heterogeneous disorder. The phenotype of BWS is likely to result from an imbalance of a number of critical genes at chromosome 11p15. In BWS, 85% of cases are sporadic and 15% are autosomal dominant. In BWS, the most common phenotype are: macroglossia, abdominal wall defects, increased growth (birth weight and length, visceromegaly, hemihyperplasia, ear lobe crease). Our case report is about a 1 month old newborn female; any sort of problem was reported in family history and gestational anamnesis was completely negative. She was born at 38 week of gestational age with normal auxological evaluation except for weight (> 90° centile). Biochemical evaluation do not show any sort of pathological parameter. During follow up at 15 day and 1 month, we discovered an alteration of legs measure: in particolar left leg was lager than right one; for this reason, we begin a genetic evalutation with final diagnosis for BWS.This case report underlines the importance of newborn precocious clinical evalutation after birth durino first month of life: a normal newborn, sometimes, could mask an important clinical problem.
T1:PO.20
Tungstate antiobesity effects require intact leptin system Aims: Assess the role of leptin in the tungstate antiobesity effects. Methods: Ob/ob and lean mice were treated with tungstate (180mg/Kg/day) for 30 days. Body weight (BW) and food intake (FI) were measured daily. Oxygen consumption was determined by indirect calorimetry. Epididymal adipose tissue (epWAT) from lean mice was transplanted subcutaneously into ob/ob mice and tungstate was administered for 4 weeks. An additional control group of ob/ob mice transplanted with ob/ob epWAT was used as a leptin deficiency control. Fat transplants were removed and tungstate treatment was carried out for additional two weeks. Results: Tungstate treatment significantly reduced BW gain, adiposity and FI, and increased oxygen consumption in lean mice. However, in treated ob/ob mice none of these parameters were significantly changed. From second week onwards, ob/ob mice transplanted with epWAT from lean mice showed a decrease in BW gain compared to transplanted control mice, related to the onset and rise of plasmatic leptin levels. In addition, FI and oxygen consumption were reduced and increased respectively in these animals. These effects were amplified in transplanted ob/ob mice treated with tungstate. Moreover, morphological differences in brown adipose tissue were observed in transplanted untreated ob/ob mice, which are more accentuated in treated animals. Finally, the removal of transplanted adipose tissue from the treated mice immediately halted tungstate antiobesity effects, thus increasing BW and FI. Conclusions: Tungstate require leptin to exert its antiobesity effects through increasing energy expenditure and reducing FI.
Abstracts
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International Journal of Obesity We assessed whether the APOA5 S19W, T-12,238C, APOA4 T347S, and APOC3 C-482T and C3238G (SstI) polymorphisms may be associated with susceptibility to the metabolic syndrome and/or with the clinical variables related to the metabolic syndrome (waist circumference, blood pressure, plasma glucose, triglyceride and HDL-cholesterol levels). We genotyped for these 5 polymorphisms 3 population-based samples from the east (n=953), south (n=1082) and north (n=1103) of France including overall 932 individuals with and 2206 individuals without metabolic syndrome. We detected significant associations between the APOA5 19W (P<0.0001) and APOC3 3238G (P=0.02) alleles and higher plasma triglyceride levels. Moreover, the APOA5 19W allele conferred an increased risk of metabolic syndrome compared with S19S genotype (OR=1.30 [1.03-1.66]). Haplotype analysis revealed that the effect of the APOA5 S19W polymorphism and APOC3 C3238G polymorphisms on plasma triglyceride levels were independent from each other. Finally, there were statistically significant interactions (i) between waist girth, plasma triglyceride levels and the APOA5 S19W polymorphism i.e. plasma triglyceride level differences between carriers and non-carriers of the 19W allele were more pronounced in subjects with abdominal obesity than in those with low waist girth, and (ii) between plasma insulin levels, plasma triglyceride levels and the APOC3 C-482T polymorphism i.e. plasma triglyceride level differences between carriers and non-carriers of the -482T allele were more pronounced in subjects with insulin resistance than in those with low insulin levels. These data confirm that genetic variability in the APOA5-A4-C3 locus regulate -in a complex manner-plasma triglyceride levels and modulate the risk of metabolic syndrome in humans. Background: Recently, we shown that obese ob/ob mice receiving ethanol (2.5 g/kg) daily for 4 days exhibited TNF-alpha-dependent apoptosis in liver and some resistance to ethanolinduced oxidative stress when compared to lean mice (Robin et al., Hepatology 2005) . Aim of the study: To determine the effects of chronic ethanol intoxication (CEI) in obese mice. Methods: C57BL/6J-ob-ob mice and their lean littermates received increasing amounts of ethanol in water reaching 21g/kg/d after 6 months. Results: CEI did not induce hepatic cytolysis and decreased hepatic triglyceride levels by 20%. Moreover, CEI induced an important loss of body weight, and an apparent improvement of insulin resistance with a significant reduction of blood glucose and insulin. Although intoxicated ob/ob mice ate less than naïve ob/ob mice throughout the treatment, the loss of calorie intake was fully compensated with the calories supplied by ethanol. However, despite the lack of hepatic cytolysis, CEI caused a moderate oxidative stress in ob/ob liver with decreased aconitase and glutathione S-transferase activities and increased oxidized glutathione. CEI in lean mice did not affect body weight, liver triglycerides and blood glucose. Though hepatic oxidative stress was detectable in lean mice it was somehow reduced when compared to ob/ob liver. Conclusions: CEI improves some metabolic disorders in ob/ob mice (e.g. fatness, insulin resistance, steatosis). Although CEI induces a moderate oxidative stress in liver, this was not accompanied by cytolysis. We are currently performing microarray analyses in liver to assess the expression of genes involved in fat and glucose homeostasis and oxidative stress.
T1:PO.23
Increased fatty acid oxidation in liver is involved in the body fat-lowering effect of trans-10,cis-12 conjugated linoleic acid in adult hamsters In previous studies we have demonstrated that one of the mechanisms underlying the reduction in body fat accumulation induced by trans-10,cis-12 conjugated linoleic acid (CLA) in young hamsters is an increase in both mitochondrial and peroxisomal fatty acid oxidation in liver. The purpose of the present work was to determine whether this CLA effect is maintained in adult hamsters, in which the body fat-lowering effect of CLA is lower than that observed in young hamsters. Sixteen male Syrian Golden hamsters (8-month-old) were divided into two groups and fed high-fat diets containing 0.5% linoleic acid (control group) or 0.5% trans-10,cis-12 CLA for 6 weeks. Liver triacylglycerol content, as well as carnitine-palmitoyl transferase I (CPT-I) and acyl CoA oxidase (ACO) activities were assessed by spectrophotometry. Hamsters fed the trans-10,cis-12 CLA-enriched diet showed an increase in liver size when compared with the controls (8.33±0.42 g vs 10.07±0.36 g; P < 0.01), not due to increased triacylglycerol accumulation (3.95±0.98 mg/g vs 3.65±0.30 mg/g). Trans-10,cis-12 CLA increased ACO activity (1.96±0.34 nmol/min/mg protein vs 3.12±0.48 nmol/min/mg protein; P < 0.05), but CPT-I activity remained unchanged (7.19±0.95 nmol/min/mg protein vs 8.12±0.14 nmol/min/mg protein). These results show that, in adult hamsters, liver is a target organ for trans-10,cis-12 CLA because this isomer increases hepatic microsomal fatty acid oxidation. Nevertheless, it is important to emphasize that the age has an influence on this effect because young hamsters showed a greater increase in peroxisomal fatty acid oxidation and also an increase in mitochondrial fatty acid oxidation after CLA feeding. Research relating to this abstract was funded by Ministerio de Educación y Ciencia (AGL2005-02494).
T1:PO.24
Increased cortisol level in type 1 diabetic patient may lead decreasing of bone mineral density Objective: In this study we aim to investigate the association of osteoporosis and type 1 diabetes in 43 type 1 diabetic subjects and 41 control subjectes. Subjects and Methods: Bone mineral density of both groups were measured by DEXA. Age, BMI, waist/ hip ratio, daily calcium consumption were determined in both groups. Twenty-four hours urinary calcium, phosphorus, deoxipyridinoline and pyridinoline were measured. Osteocalcin ALP, IGF-1, IBF-BP3. HbA1c, cortisol, albumin, LDL and triglyceride were measured in both groups. Independent t-test and chi-square test were used to compare the groups. Results: Age, body weight, BMI, waist/ hip ratio, daily calci•um consumption of diabetics were not different from the control group (P>0.05). Total lumbal BMD (0.88±0.1; 0.93±0.1 g/cm² respectively; P<0.05) total femur BMD (0.93±0.14, 0,99±0.1 g/cm² respectively; P<0.05) and total femur Z-score (-0.16±1, 0.53±0.7 respectively; P<0.005) of the diabetic group were statically lower than control group. Urine DPD/ creatinine level (7.6±6.1, 4.9±3.8 pmol/µmol, respectively; P<0.05), serum ALP level ( 113±62, 74±18 U/L respectively; P<0.001), IGF-BP3 level (5.4 ±0.9, 4.7±1 µg/ml respectively; P<0.001) of diabetic groups were statically higher than control group. Serum cortisol levels in diabetic group were statically higher than control group (14.7±3, 12.8±2.7 µgr/dl respectively; P<0.005). Conclusions: 1-Bone mineral density of type 1 diabetic patient were decreased due to increased bone turnover 2-Increased cortisol level in type 1 diabetic patient may lead decreasing of bone mineral density. Obesity is now the most common nutritional disorder of companion animals . A role for inflammation-related adipokines in the development of obesity -associated diseases in humans is increasingly recognised. TNF-•, a pleiotropic proinflammatory cytokine, has been shown to play an extensive role in ad ipose tissue function. The quantitative expression profile (qPCR) of a series of in flammation-related adipokine genes was examined during the differentiation of canine preadipocytes to adipocytes in culture. The effects of TNF-• on the expression of these adipokines wa s also investigated. No significant difference was found in inflammatory adipokine mRNA levels between five major canine white adipose tissue depots (subcutaneous, perirenal, omental, gonadal and falciform ligament). Leptin and adiponectin expression was highly differentiationdependent. NGF, a target derived neurotropin, was found to be expressed in c anine WAT. Its expression pattern was found to mirror that of other inflammationrelated adipokines such as IL-6 and TNF-•, with levels being higher early in the di fferentiation process. Treatment of differentiated canine adipocytes with TNF -• (5 or 50 ng/ml for 2 or 24 h) significantly reduced the mRNA level of leptin (acute -2 h) and adiponectin (chronic -24h). In contrast, TNF -• induced substantial increases in several adipokines mRNAs including IL-6 (18-fold), MCP -1 (17-fold) and NGF (4 -fold), the largest increase being in TNF-• itself (1868 -fold). These results demonstrate that there are significant qua ntitative changes in the level of adipokine gene expression during differentiation in canine adipocytes and that TNF -•exerts a pleiotropic effect on adipokine production in the dog. Payment received from the BBSRC Research relating to the abstract was funding by both the BBSRC and WALTHAM Centre for Pet Nutrition.
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T1:PO.28
Inhibition of 3T3-L1 adipocyte differentiation by oxidized-ldl: enhanced ccaat/enhancer-binding protein α mRNA and protein levels Adipocyte differentiation occurs through temporal pattern of expression of adipogenic genes that give rise to the adipocyte phenotype. Abnormal regulation of adipocyte differentiation is linked to pathological conditions such as obesity and diabetes. Oxidised low-density lipoproteins (ox -LDL) play a critical ro le in the regulation of cell proliferation, apoptosis and differentiation and are associated to obesity. Aim of the study was to investigate the effects of ox-LDL on the differentiation of 3T3 -L1 preadipocyte s cell line. To this end, in the presence or absence of ox -LDL (0.05mg/ml), postconfluent 3T3 -L1 preadipocyte s were induced to differentiate by standard ho rmonal mixture. In both the experimental conditions, during the progression of differentiation, we evaluated:1) cell proliferation by 3H -thimidine incorporation, 2) induction of apoptosis by Annexin V analysis, and 3) expression of C/EBP • both at RNA and protein level by RT -PCR and western blotting respectively. Our results showed that ox-LDL, significantly, 1) inhibited differentiation without affecting cell proliferation 2) did not induce apoptosis in 3T3 -L1 cell line, as observed in se veral different cell types, 3) and caused a sustained upregulation, up to five days after differentiation induction, of C/EBP • mRNA transcription associated to an increased nuclear accumulation of C/EBP • protein. It is known that o x-LDL have mitogenic e ffects and that C/EBP • is a promitotic factor, thus our data suggest that ox-LDL are involved in the dysregulation of the adipose tissue homeostasis by affecting the number of preadipocytes due, at least partially, to altered levels of C/EBP •.
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International Journal of Obesity Objective: Abdomial visceral (VAT) and sub-cutaneous adipose tissue (SAT), with SAT comprised of superficial-SAT (sSAT) and deep-SAT (dSAT), are metabolically distinct. Anti-diabetic agents thiazolidinediones (TZDs), in addition their insulin-sensitizing effects, re-distribute SAT suggesting TZD-action involves adipose tissue strata-specific regulation. We investigated the expression of proteins key to adipocyte metabolism in rosiglitazone treated preadipocytes, to establish a role for the diverse strata of abdominal adipose tissue in the insulin-sensitizing effects of TZDs. Methods: Adipocytes and preadipocytes were isolated from sSAT, dSAT and VAT samples obtained from 5 normal to over-weight subjects (BMI 24.5±2.04kg/m 2 ; age 58.4±5.7yrs). Preadipocytes untreated (U) or treated with a differentiation cocktail (DI) including rosiglitazone (DIR) for 9days, were evaluated for strata-specific differences in differentiation, including peroxisome proliferatoractivated receptor (PPAR ) and lipoprotein lipase (LPL) expression, insulin sensitivity via adiponectin, glucose transport-4 (GLUT4) and resistin, glucocorticoid metabolism with 11 -hydroxysteroid dehydrogenase type-1 (11 HSD1) and alterations in the adipokine leptin. Results: While strata-specific differences were absent with the classic differentiation cocktail, with rosiglitazone sSAT had the most potent response followed by dSAT, while VAT was resistant to differentiation. With rosiglitazone, universal strata effects were observed for PPARγ, LPL, resistin and leptin, with VAT in all cases except resistin, expressing significantly lower expression levels. Clear dSAT-specific changes were observed with decreased intracellular GLUT4. sSAT-specific alterations included decreased 11 HSD1, while secreted adiponectin was potently upregulated with respect to dSAT and VAT.
Conclusions:
The sub-strata of SAT, sSAT and dSAT, appear to be key to the metabolic changes that arise with rosiglitazone administration.
T1:PO.30
Differential lipolytic regulation in human embryonic stem cell-derived adipocytes The relationship among polymorphism alleles of selected genes with the degree of obesity, as well as of the effect of reduction therapy in a spa (5-6 weeks, diet and exercise) in Czech obese subjects (42 obese boys and 72 girls) was analyzed, using Mann-Whitney test. In the carriers of PPARgamma 2, polymorphism Pro12Ala no statistically significant associations with biochemical and anthropometric parameters were found. In obese girls no statistically significant relationships with biochemical and anthropometric parameters and their changes after reduction therapy were observed as related to UCP1, polymorphism A-3826G gene. In obese boys, in carriers of rare genotype GG a lower body weight decrease and a smaller increase of the percent of muscle tissue were found as compared to common genotype AA. As related to polymorphism Gln27Glu in gene Beta2AR, no significant associations among anthropometric and biochemical parameters characterizing glucose and lipid metabolism were revealed. Male homozygotes Glu2/Glu had smaller percentual decrease of abdomen circumference as compared to homozygotes Glu/Glu. Female homozygotes Glu/Glu had significantly lower percentual decrease of body weight as compared to heterozygotes. The presence of Glu allele in genotype was associated with lesser effect of reduction therapy in both genders. The presence of long alleles in genotype INS VNTR could have a positive effect on weight reduction in girls, not in boys. Polymorphism Ala 54 Thr in Gene FABP2 had no association with biochemical parameters of insulin secretion and lipid metabolism. Genotype Thr/Thr can lower the effectiveness of reduction therapy in girls, not in boys. The study was supported by a research grant of the Ministry of Education, Youth and Sports of CR, grants No. MSM 0021620843 and 1M06014.
T1:PO.32
Effects of resveratrol on human adipocyte biology Objectives: Calorie restriction (CR) leads to retardation of the aging processes and to longer life in many organisms. The effect of CR can be mimicked by certain natural plant products, e.g. some flavonoids and most efficiently by resveratrol, a sirtuin activating compound, which is present in grapes and red wine. This intriguing finding raises the question whether simply taking a chemical would counteract all the bad effects of being overweight without changing eating habits. In this study, we have investigated the effects of resveratrol on human fat cell biology.
Methods: As a model system we have used human SGBS preadipocytes and adipocytes. Adipogenic differentiation was determined by morphological means. Apoptosis was studied by flow cytometry. In addition, de novo lipogenesis and effects on gene expression were investigated. Results: Resveratrol inhibits human preadipocyte proliferation and, under special conditions, induces apoptosis in preadipocytes and adipocytes. Adipogenic differentiation was inhibited in a time-and dose-dependent manner. Incubation with low doses of resveratrol resulted in suppression of de novo lipogenesis. In addition, incubation with resveratrol differentially influenced gene expression of adipocytokines. While expression of leptin and adiponectin was unaffected, IL-6 and IL-8 were significantly down-regulated.
Conclusions:
Taken together, our data show that resveratrol inhibits human preadipocyte proliferation, conversion into mature adipocytes, and de novo lipogenesis, and induces apoptosis under special conditions. In addition, it inhibits production of cytokines which are involved in the development of obesity-related disorders. These data suggest that resveratrol might exert positive effects on adipocyte biology in vivo.
Funding:
Research relating to this abstract was in part funded by the Deutsche Forschungsgemeinschaft (DFG WA 1096/3-2).
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Conjugated linoleic acids promote human fat cell apoptosis Conjugated linoleic acids (CLA) are conjugated dienoic isomers of linoleic acid. Some isomers have been shown to reduce fat mass in animal and cell culture models. However, controversial results were obtained in studies of CLA supplementation in human subjects. In order to get more insights into the direct effects of CLA on human fat cells, we have studied the influence of cis-9, trans-11 CLA and trans-10, cis-12 CLA on the biology of human SGBS preadipocytes and adipocytes. Both CLA isomers equally inhibited the proliferation of preadipocytes in a dosedependent manner. Continuous treatment with 1-10 µM trans-10, cis-12 CLA, and to a weaker extent cis-9, trans-11 CLA inhibited accumulation of lipids during adipogenic differentiation. Treatment with higher doses of CLA induced apoptosis in preadipocytes, in differentiating cells, and adipocytes. The trans-10, cis-12 isomer had a higher apoptotic potency in adipocytes than cis-9, trans-11 CLA. Taken together, the treatment of human preadipocytes and adipocytes with physiological relevant concentrations of CLA resulted in an impairment of proliferation and differentiation and induction of apoptosis. The trans-10, cis-12 isomer was more potent than the cis-9, trans-11 isomer.
Further clinical studies are needed to evaluate the effects of CLA on human fat mass and metabolism in vivo.
Funding:
T1:PO.34
Apelin gene expression of white adipose tissue is regulated by cafeteria diet and vitamin C supplementation in rats r=0.701; P<0.001, r=0.692; and P<0.01, r=0.563) . Discussion: It has been shown that vitamin C could be a protective factor of cafeteria induced overweight. Clear associations between apelin mRNA expression from Sc WAT and several markers of adiposity, insulin resistance, liver oxidative stress and inflammation were observed, suggesting an important role for apelin in the excessive weight gain induced by high-fat diet in rats.
T1:PO.35
AGTR1 gene expression is down-regulated in obese compared to lean young male high-fat consumers Marrades Maria Pilar 1 , Martínez J.Alfredo 1 , Moreno-Aliaga Maria Jesus 1 1 University Of Navarra
Objective: The aim of the present study was to compare the AGTR1 gene expression in subcutaneous abdominal fat from lean vs. obese high fat intakers with a similar physical activity patterns. Subjects and methods: Eighteen young men, 9 lean (BMI=23.1±0.4 kg/m 2 and 9 obese (34.7±1.2 kg/m 2 ) with a similar habitual dietary intake of fat (44.6±2.2 vs. 42.5±1.8% daily energy from fat and physical activity (17.5±5.1 vs. 18.0±4.4 METsh/week) for lean and obese, respectively), were recruited. Subcutaneous abdominal fat biopsies were obtained and total RNA was extracted, purified and probed into Affymetrix GeneChip Human U133A. The microarray data was verified by Real-time PCR (ABIPRISM 7000). Results: Both the microarray and real-time PCR analysis revealed that AGTR1 gene was down-regulated in subcutaneous adipose tissue of obese compared to lean subjects. Moreover, we observed a significant association between AGTR1 gene expression and the QUICKI index: (P<0.05, r=0.58). Discussion: The decreased expression of AGTR1 gene in subcutaneous adipose tissue of obese subjects and their correlation with the lower insulin sensitivity suggest that renin-angiotensin-system (RAS) could be involved in the susceptibility to develop obesity and insulin resistance when eating a high fat diet.
T1:PO.36
A common polymorphism (-3185C>T) in the promoter of the visfatin gene (PBEF1) influences plasma insulin levels in a Greek women population 3 Nutrition and Genomics Laboratory, JM-USDA -HNRCA at Tufts University, Boston, Massachusetts, USA Visfatin (PBEF1) is a novel insulin-mimetic adipocytokine which has been suggested to play a role in glucose homeostasis and may represent a link between central obesity and insulin resistance. In the present study we explored potential associations between two common single nucleotide polymorphisms in the promoter of the visfatin gene (rs11977021: -3185C>T and rs1319501:-423A>G) and adiposity-related phenotypes in 345 non-diabetic women (mean age: 47.0 ± 12.1 y) with a wide spread of BMI ranging from 18.5 to 47.4 kg/m 2 (mean: 29.0 ± 5.5 kg/m 2 ). We did not find statistically significant differences in genotype distributions or allele frequencies for the two polymorphisms between normal weight, overweight and obese women (minor allele frequencies in whole group: -3185T=0.27; -423G=0.24). Moreover, no significant associations were observed between any of the two polymorphisms with body composition (assessed by anthropometry and dual energy x-ray absorptiometry), fasting plasma lipid or glucose levels, except for a weak association between the -3185C>T polymorphism and plasma insulin levels (P=0.05). In multivariate analysis controlling for potential confounders, carriers of the minor -3185T allele had lower fasting insulin levels compared with carriers of the -3185C/C genotype (8.04 ± 3.88 mIU/L vs. 9.31 ± 5.30 mIU/L, P=0.04) and had lower homeostasis model assessment of insulin resistance (HOMA-IR) index (1.90 ± 0.96 vs. 2.23 ± 1.35, P=0.05). These data suggest that variation in the promoter region of the visfatin gene may not play a major role in the development of obesity in humans; however, the -3185C>T polymorphism may be associated with insulin resistance.
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Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in non-diabetic Greek women In this study we examined the associations between two single nucleotide polymorphisms (SNPs) in the adiponectin gene (+45T>G and +276G>T) and risk factors of type-2 diabetes in 350 non-diabetic Greek women (mean age: 47.0 ± 12.1 y, mean BMI: 29.5 ± 5.6 kg/m2). No association of the +45T>G or the +276G>T SNP with BMI, body composition variables and plasma lipid levels was observed. However, in multivariate analysis controlling for potential confounders both SNPs were found to be associated with insulin resistance (assessed by HOMA-IR index, P<0.05). In particular, carriers of the rare +45G allele exhibited lower fasting plasma insulin levels than did homozygotes for the +45T allele (7.88 ± 4.15 mIU/L vs. 8.89 ± 4.76 mIU/L, P=0.009) and had lower HOMA-IR (1.86 ± 0.99 vs. 2.12 ± 1.23, P=0.01). At position +276, carriers of the T allele had higher fasting insulin levels and higher HOMA-IR compared to +276G/G homozygotes (9.40 ± 5.32 mIU/L vs. 8.07 ± 3.96 mIU/L, P=0.003 and 2.25 ± 1.34 vs. 1.90 ± 1.00, P=0.002, respectively). SNPs 45 and 276 were not in linkage disequilibrium (R = 0.26) and haplotype analysis revealed that carriers of the +45T/+276T haplotype had significantly higher insulin levels and HOMA-IR than did non-carriers (9.40 ± 5.32 mIU/L vs. 7.99 ± 3.78 mIU/L, P=0.002 and 2.25 ± 1.34 vs. 1.88 ± 0.97, P=0.002, respectively). We conclude that the +45T>G and +276G>T polymorphisms in the adiponectin gene modulate insulin sensitivity and that haplotype +45T/+276T is a risk haplotype for insulin resistance in Greek women.
T1:PO.38
Ranking of redox potential between CHD risk factors. Plasma ischemia modified albumin (IMA), hsCRP and Chlamydia pneumoniae seropositivity in obese/metabolic syndrome patients About fifty percent of patients presenting acute coronary syndrome who does not display classical risk factors, remain inaccessible for prevention. Plasma hsCRP and ischemia modified albumin (IMA) were recently introduced as more informative cardiovascular risk markers. The intracellular bacterium Chlamydia pneumoniae is involved in the inflammation process of atherosclerosis. Aim of study: was to assess the relation between C. pneumonie infection, plasma hsCRP and IMA level and oxidative stress/antioxidant plasma capacity. Methods: A total of 83 men included in the study consisted of: cardiovascular event-free obese (BMI >30; < 35kg/m 2 ) men (O) without others CHD risk factors, and the control group (C) of healthy subjects. The lipoprotein profile, plasma hsCRP, IMA, markers of oxidative stress, antioxidant plasma capacity, and C.pneumoniae antibodies were measured. Results: Plasma hsCRP and IMA/alb directly correlated with the body fat in whole group. Examination of high score IMA/alb ratio and hsCRP patients compared to reference group revealed low antioxidant level, oxidative alteration of LDL, higher plasma content of LOOH, TBARS, and reduced redox compensation index. Percentages of subjects from C and O groups positive for C.pneumoniae antibodies were associated with IMA/alb ratio in the highest group quartile. Markedly decreased plasma antioxidant capacity and increased oxidative stress characterized antibodypositive subjects. Conclusion: Plasma hsCRP, C.pneumoniae antibody index as well as IMA score may serve as potential marker of oxidative stress and low antioxidant status.
T1:PO.39
Comparison of luminex and ELISA techniques for measuring circulating IL6, TNF? and MCP-1 in obese subjects Aims: Multiplex techniques provide the opportunity to screen a large number of proteins using a small sample volume, but results and precision relative to the standard ELISA technique is not clear. This study compares results for 3 inflammatory markers, obtained using the two techniques. Methods: 74 subjects, recruited from the Cambridge area, with fasting blood samples were included in the study. IL6, TNF α and MCP-1 were measured using an ELISA technique (R&D Systems, Minneapolis, MN, USA) and a bead -based luminex technique (BioRad, Hercules, CA, USA). Serum C reactive protein (CRP) was measured as an independent index of inflammation (high sensitivity assay, Dade -Behring, Walton, UK). Bland Altman analysis was used to assess the agreement between the two methods. Correlation was used to further explore the relationship between the 3 markers of inflammation. Results: Baseline TNFα was undetectable in 63 subjects using the luminex method. Scattergraphs and Bland Altman plots show poor agreement between the two methods (correlation coefficients for each of the 3 inflammatory markers TNFα r=0.16, Introduction: Recent data suggest that the endocannabinoid system is a key circuit controlling food intake and the cannabinoid receptor (CB1) has emerged as a target for pharmacotherapy for obesity. With this study, we wanted to assess whether CNR1 G1422A genotype contributes to the development of obesity in the Belgian population. Furthermore, we investigated whether the G1422A variant is associated with obesity parameters in adult obese individuals. Patients and methods: 161 healthy controls and 1093 obese subjects were included in this study. Anthropometric measurements were obtained and fat mass was assessed by bio-impedance. CNR1 genotypes were analysed by TaqMan. Kruskall-Wallis and MannWhitney-U tests were performed for different endophenotypes, before and after controlling for age and BMI. Results: The G1422A allele frequencies did not differ significantly between cases and controls (OR 0.94; P=0.619). Among premenopausal obese women, no significant associations between genotype groups and anthropometric parameters could be detected. In obese men, CNR1 genotype was significantly associated with WHR, both unadjusted (P=0.022) and adjusted for age and BMI (P=0.032). Fat mass percentage also showed an association (P=0.007), which disappeared after adjusting for age and BMI.. Waist was associated with CNR1 genotype (P=0.017) after the same adjustments. A trend for an association with fat mass was also observed (unadjusted p=0.088; adjusted P=0.066). Conclusion: Our data do not indicate that the G1422A polymorphism in the cannabinoid receptor-1 gene is involved in the pathogenesis of obesity in our study population. The variant is, however, associated with increased abdominal adiposity in obese men.
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Two novel mutations in the melanocortin-4 receptor associated with earlyonset obesity Introduction: Obesity is a major health problem in industrialized countries. In a minority of cases obesity has been associated with a mutation in one gene. Currently, six such monogenic forms of obesity have been described. Melan ocortin-4 receptor deficiency is most common and the goal of the present study was to investigate whether pathogenic melanocortin-4 receptor (MC4R) mutations are a common cause of early -onset obesity in Belgium. Patients and methods: A total of 165 obese children and adolescents were screened for mutations in MC4R with the WAVE Nucleic Acid Fragment Analysis System (Transgenomic, Inc.). Direct sequencing was performed when the chromatogram deviated from the WT pattern. Results: DHPLC screening identified 7 patients with a variation in MC4R (frequency = 4 .24%).Two adolescents harboured the common Val103Ile polymorphism and two other patients contained the Ile251Leu polymorphism. One obese child was heterozygous for the Thr112Met polymorphism. Additionally 2 novel amino acid changes in MC4R were discovered. One obese child carried a Phe280Leu substitution, while a second patient harboured a Pro260Gln change. Both these children suffer from obesity from an early age. These variants were not found when screening 100 healthy controls. Conclusion: Screening of children and adolescents with early -onset obesity revealed two novel mutations in MC4R. Further functional characterization is necessary to fully understand the pathogenic effect of these mutations. The aim of this study was to determine whether an association between sleep duration and obesity exists in a sample of Portuguese children. A cross-sectional study of children 7 to 9.5 y old was performed between October 2002 and June 2003. A total of 2274 girls and 2237 boys were observed. Weight and height were measured, and parents filled out a questionnaire about family characteristics. Overweight and obesity, using age-and sex-specific body mass index (BMI) cut-off points as defined by the International Obesity Taskforce, were used. In the total sample we found 20.3% of overweight children and 11.3% of obese children. The prevalence of obesity (including overweight) decreased by duration of sleep: > 8 h, 49.1%, 8-9 h, 33.0%, 9-10 h 28.7 % and > 11 h, 26.3%. Parental education showed positive relationship with sleeping: children of more educate families showed more hours of sleeping; more TV hours showed a negative relationship with sleeping: more hours of TV less hours of sleeping; more physical activity showed a positive association with sleeping: more hours of physical activity more hours of sleeping. After adjusted for demographic factors such as parental obesity, parental education and TV, the odds ratio were: for sleeping 9-10 h, 1.07 (95% CI 1.06-1.07); 8-9 h, 1.14 (95% CI 1.11-1.16) and < 8 h, 2.28 (95% CI 2.27-2.29). The effect of sleep duration on childhood obesity is strong and seems to be independent of other risk factors associated with childhood obesity.
T1:PO.43
Towards leptin-derived peptides in cancer therapy: Partial agonists acting on the leptin -leptin receptor interface Obesity significantly increases the risk of cancer development, possibly through increased expression of leptin. High local leptin levels might promote carcinogen esis by inducing mitogenic cell response and thus, targeting leptin signaling represents a nov el cancer treatment option. Leptin mutants were shown to antagonize the protein's activity in vitro, but the lack of clinical success with full -sized leptin prompted us to search for a peptide -based leptin -receptor antagonist. Individual arms of the three bivalent receptorbinding leptin fragments, their reportedly antagonist analogs, as well as a synthetic construct comprising both surf aces of site II were synthesized and their ability to stimulate MCF -7 mammary carcinoma, DU -145 prostate carcinoma and M CF-10 normal mammary epithelial cells were studied. While none of the peptides influenced the proliferation of normal cells, the site II construct and an alanine mutant of site III reversed leptin -induced growth of cancer cells in the 10 -100 nM concentration range. However, at a 10 -fold increased concentration, the same peptides showed growth promoting activity without exogenous leptin addition, suggesting that these leptin fragments are partial agonists rather than true antagonists. In addition, the more drug-like site III derivative underwent rapid exopeptidase cleavage, prompting us to design a second generation of site III analogs containing non -natural amino acid residues incorporated into strategic positions throughout the peptide. These leptin derivatives serve as lead compounds for further medicinal chemistry operations in order to develop a true leptin-receptor antagonist in cancer therapy of obese patients.
T1:PO.44
Water extracts of Paecilomyces tenuipes inhibit 3T3-L1 adipocyte differentiation induced by cathepsin Osteopontin (OPN), a cytokine involved in various inflammatory diseases, plays an important role in the progression from liver steatosis to Nonalcoholic steatohepatitis (NASH) in mouse models of Nonalcoholic fatty liver diseases (NAFLD). We determined the hepatic gene expression levels of OPN and its cellular receptor CD44 in obese patients with or without steatosis and steatohepatitis. Liver biopsies were obtained from 47 severely obese patients undergoing bariatric surgery and 6 control subjects. Steatosis was graded 0 to 3 based on the percentage of hepatocytes with micro-or macro-vesicular steatosis (S0, none; S1< 30%; S2, 30-60%; and S3>60%). Among obese patients, 39 had steatosis alone (6 S0, 13 S1, 9 S2, 11 S3) and 18 had NASH (1 S1, 6 S2, 11 S3). OPN and CD44 gene expression was determined by real-time quantitative PCR. In patients with severe steatosis (S3), the OPN and CD44 gene expression was strongly increased compared with controls or obese patients without steatosis (S0). These high expression was similar in severe steatosis without or with steatohepatitis. The OPN protein expression, evaluated by immunoblotting, was also related to the severity of steatosis. Finally, OPN and CD44 gene expression was correlated with circulating alanine amino-transferase levels (an index of liver alteration) and insulin resistance. The progression from moderate to severe steatosis, which could be considered as a pre-NASH state, was accompanied by an upregulation of OPN and CD44 expression, which, in association with insulin resistance, could contribute to the pathogenesis of NAFLD in severely obese patients.
T1:PO.46
Plasma levels and adipose tissue expression of retinol-binding protein 4 are reduced during diet-induced weight loss in obese subjects but are not associated to changes in insulin sensitivity Background: Retinol-binding protein 4 (RBP-4) is produced by adipose tissue and has been suggested to play a role in the development of insulin resistance. Aim: To investigate whether a diet-induced weight loss associated with improvement of insulin sensitivity induces changes in RBP-4 expression in adipose tissue and plasma levels. Methods: 24 obese women (body weight 97.3±15.7kg) were studied at basal conditions, after a 4 week very low calorie diet (VLCD) and 5-6 months later during the weight-maintenance phase (WM). Insulin resistance was assessed with euglycemic hyperinsulinemic clamp. Plasma and subcutaneous adipose tissue mRNA levels of RBP-4 were measured by ELISA and RT-qPCR, respectively. Results: The weight loss was 7.4±1.7kg and 10.4±4.6kg after VLCD and at WM, respectively. Glucose disposal increased by 34.9% after VLCD and 57.5% at WM compared to the basal state. Plasma levels of RBP-4 were reduced after VLCD and at WM (B: 27.4±7.2; VLCD : 20.1±5.1; WM: 23.0±5.5µg/ml, P<0.01). Adipose tissue mRNA levels decreased 1.5 fold during VLCD and re-increased during WM. No correlations between diet-induced changes in RBP-4 production and insulin sensitivity indices were found. Conclusion: The insulin sensitizing weight loss program promotes a reduction of RBP-4 plasma levels and adipose tissue expression. The study did not bring a direct evidence of the role of RBP-4 in the regulation of diet-induced changes in insulin sensitivity. The study was supported by grant GACR 04/0158 and EU program HEPADIP.
T1:PO.47
The Arg223Arg genotype of the leptin receptor gene is associated with obesity in Hungarian children The activity of brown adipose tissue (BAT), a site of non-shivering metabolic thermogenesis, has been reported to increase after interleukin (IL)-1ß/lipopolysaccharide injection. To clarify the possible contribution of BAT thermogenesis to whole body febrile response, we investigated febrile and thermogenic response to IL-1ß using mice deficient in uncoupling protein (UCP) 1, a key molecule for BAT thermogenesis. In wild-type (WT) mice, intraperitoneal injection of IL-1ß (5•g/kg) increased plasma corticosterone level and body temperature, and decreased physical activity, and produced a slight and insignificant rise in oxygen consumption (VO 2 ). VO 2 dependent on metabolic thermogenesis (VO 2-thermogenesis ) calculated by correcting the effect of physical activity was increased after IL-1ß injection (726 ± 200 ml/h/kg at 1 hr). Almost the same responses were observed in UCP1-deficient mice, showing 638 ± 87 ml/h/kg of VO 2-thermogenesis at 1 hr. In contrast, intraperitoneal injection of CL316,243 (100g/kg), an activator of BAT thermogenesis, increased body temperature, decreased physical activity, and produced a significant rise in VO 2 in WT mice, showing 1229 ± 35 ml/h/kg of VO 2-thermogenesis at 1 hr. Such changes were not obsereved in UCP1-deficient mice, and VO 2-thermogenesis at 1 hr was 71 ± 103 ml/h/kg. These results, conflicting with a previously proposed idea of a role of BAT in fever, suggest a minor contribution of BAT thermogenesis to IL-1ß-induced fever. In support of this, we found no effect of IL-1ß on triglyceride content and UCP1 mRNA level in BAT, in contrast with apparent effects of CL316,243.
T1:PO.50
Association of MKKS gene polymorphisms with obesity in Greeks Introduction: Obesity is a widely spread multifactorial disease accompanied with a variety of other abnormalities. At present, more than six hundred genes, markers and chromosomal regions are linked with human obese phenotype. The aim of this study was to evaluate the association of seven MKKS gene polymorphisms (SNPs) with obesity in Greeks. Methods: 220 obese (BMI>30Kg/m 2 ) individuals and 120 non-obese unrelated subjects (controls) were studied. DNA was extracted from peripheral blood and polymorphisms were analyzed by PCR/RFLPs or sequencing. Mean values of biochemical variables were calculated and compared between carriers and noncarriers of different alleles for each polymorphic site. Results: The genotype frequencies of two out of the seven polymorphisms were found to differentiate statistically significant obese individuals from the controls. Specifically, the 985+16T>G variation was found mainly in obese individuals (7.85% in obese vs 1.47% in controls, P=0.0009) and G allele was found to be associated with an increase in blood pressure. Moreover, a new polymorphism (1129C>T) was detected exclusively in obese subjects (9.12%) and T allele was associated with significantly high HbA1c values (6.84±4.87 mg/dl in carriers vs 5.67±1.23 mg/dl in non-carriers, P=0.037). Twenty-six composite genotypes resulted from the combination of the seven SNPs. Two of them were found to be associated with the obese phenotype. Conclusions: This study suggests that MKKS gene SNPs are associated with genetic predisposition to obesity in Greeks. The understanding of the genetic component of obesity in combination with daily exercise and appropriate nutrition would be an effective strategy to prevent obesity.
T1:PO.51
The Introduction: Retinol Binding Protein 4 (RBP4) is synthesized in liver and adipose tissue. RBP4 serves to transport retinol from tissue storage sites to vitamin A -dependent tissues. Mice with defects in insulin action showed increased levels of rbp4 mRNA in adipose tissue and serum RBP4. Thus, alterations of adipocyte-derived RBP4 could influence insulin action. Retinoic acid (RA) treatment improves glucose tolerance and decreases the expression of resistin (an adipokine that impairs insulin action) in mice. Accordingly, RA may act on RBP4 production. Aim: To check serum RBP4 levels in rodent obesity models and RBP4 regulation by RA in murine adipocytes in vitro and in vivo. Materials and Methods: Serum RBP4 levels were determined by western blot in obese and lean Zucker rats, and in mice (NMRI and B6) fed a normal -fat diet (NF) or a high -fat diet (HF). RBP4 mRNA was determined by qPCR in RA -treated 3T3-L1 adipocytes, and adipose depots of RA-treated NMRI mice and NMRI mice fed NF or HF diet. Results: HF diet did not modify serum RBP4 levels in B6 or NMRI mice, and reduced adipose rbp4 mRNA in the latter. Serum RBP4 levels were higher in lean versus obese Zucker rats. RA treatment downregulated rbp4 mRNA in 3T3 -L1 adipocytes and in adipose depots and liver of NMRI mice. However, serum RBP4 levels were increased after RA-treatment. Discussion: According to our d ata, high circulating RBP4 levels are not extensible to all insulin-resistant and obesity models. RA exert s distinct effects on rbp4 transcription and RBP4 levels in serum. Apolipoprotein E (apo E) polymorphism may be a risk determinant of coronary heart disease (CHD), since the apo E gene polymorphism is associated with increased fasting and postprandial levels of triglycerides. The study on apoE deficient mouse documented that the elevated plasma adiponectin suppresses the development of atherosclerosis in vivo. Methods: Apo E phenotyping was performed by isoelectrofocusing method of 281 members of familial obesity group (104 men and 177 postmenopausal women). The fasting lipids, adiponectin and leptin as well as during postprandial lipemia test the insulin and triglicerides levels up to 8 hours were measured. The HOMA index as calculated.
Results: The E3/3 genotype occurred in 73.5% of the patients, followed by E3/4, E2/3, E2/4, E2/2 and E4/4 genotypes, which occurred in 15.4%, 9.6%, 0.5%, 0.5% and 0.5% of the patients, respectively. The significant difference in adiponectin and leptin concentration were observed between the group carrying the apolipoprotein epsilon4 and epsilon 2 allele. The lowest adiponectin and highest leptin concentration were characteristic for the epsilon2 allele apoE carriers. The value of leptin to adiponectin ratio was also the highest in this group. The insulin resistance index HOMA-IR was the highest in the epsilon 2 allele carriers group (the statistical significance (P=0,007) between apo E3/3 genotype and epsilon 2 allele carriers). Results: In 3T3-L1 adipocytes, 9 -cis-RA (1 mM) and all-trans-RA (1 mM) triggered a late up-regulation of visfatin mRNA (45% increase after 48 and 72 h treatment) wh ich was preceded by a down -regulation (50% reduction after 36 h treatment). Cellular visfatin protein levels followed similar changes. 1 mM rosiglitazone treatment for 24, 48 and 72 h up -regulated visfatin mRNA levels in 3T3 -L1 adipocytes. In mice, all -trans-RA treatment reduced visfatin mRNA in WAT depots, but did not affect circulating visfatin. Discussion: Up-regulation of adipose visfatin may contribute to the p roadipogenic effect of rosiglitazone. Down -regulation of adipose visfatin may contribut e to the antiadipogenic effect of RA. Late -onset up -regulation of visfatin by RA seen in 3T3 -L1 adipocytes may be part of a ne gative feedback loop to avoid fat depletion, which however is lacking in the in vivo setting used.
Conclusion.
T1:PO.60
Retroperitoneal adipose tissue in ferret (Mustela putorius furo) has a higher oxidative capacity than the interscapular adipose depot Brown adipose tissue, characterized by a high mitochondrial capacity, is primarily localized in the interscapular region in rodents, although certain species, as man and lamb, have a tissue that resembles the brown depot, but have it located mostly perirenally. Here we have studied the oxidative capacity in different adipose tissue depots of ferrets at different temperatures. For this purpose we have measured the cytochrome coxidase (COX) activity as an index of the aerobic-oxidative mitochondrial capacity in the retroperitoneal, inguinal and interscapular adipose tissue of two groups of adult ferrets, one housed at 22ºC and other acclimated to 4ºC for one week. Protein and COX activity were measured in the initial tissue homogenate and in the final mitochondrial suspension. Our data show a higher COX activity in the retroperitoneal adipose depot in comparison to the inguinal and the interscapular ones, when considering both the specific-activity (per mg of protein) and the total activity (per g of tissue), and both in the initial tissue homogenate and in the final mitochondrial suspension. In fact, contrary to what happens in rodents, the interscapular adipose tissue showed the lowest levels of enzymatic activity. No important change due to cold acclimation was observed in none of the adipose depots studied. We can conclude that the retroperitoneal adipose tissue of ferrets resembles brown adipose tissue found in other species in terms of oxidative capacity.
T1:PO.61
The effect of red grape seed on lipid serum levels of hypercholesterolemia subjects Background: Cardiovascular diseases (CVD) are of the most important causes of mortality in the world, and it has been estimated 38.5% in Iran. Dietary factors have significant influence on the control and preventive effects on CVD and lowering lipid serum levels. This study was conducted to evaluate the effects of red grape seed on the level of total cholesterol, LDL-C, HDL-C, TG and FBS of hypercholesterolemia women.
Materials & Methods:
In a clinical trial 35 hypercholesterolemia women were randomly selected in 2 groups of red (RG) and control (CG), RG included 18 subjects with 49 years old and BMI 27, CG included 17 subjects with 52 years old and BMI 28, RG group was fed 500gr red grape seed per day for 4 weeks. Control group was without any treatment. At the beginning of the study, physical activity, height, weight and BMI were determined. Lipids serum levels (TC, LDL-C, HDL-C, TG and FBS) were measured for 2 times (beginning, after 4 weeks ). Dietary intake was also determined for 6 days during the study by using 24hrs recall method. Experimental findings were analyzed statistically by suing T-test and paired t-test in software "SPSS". The amount of crude fiber and flavonoid were measured . Results: The mean levels of TC in RG group significantly decreased (-25.5 mg/dl) at the end of the 4 weeks experiment (P=0.027), also shows significance with CG (P=0.01). LDL-C level decreased significantly in RG group (-22.3 mg/dl) at the end of 4 weeks (P=0.001) and decreased significantly with CG(0.008). HDL-C, TG and FBS differences were not significant at the end of the experiment. Conclusion: Regarding the findings whole red grape seed would cause reduction of TC and LDL-C. Therefore, consumption of grapes with seeds and skin containing flavonoid and fibers were recommended to promote health. M) glycerol concentration was prolonged in subjects under anti-depressant treatment. Adipose tissue glucose concentration decreased, but showed no difference to controls. Likewise, lactate concentration increased, without any difference to controls. Adipose tissue blood flow decreased in control groups due to norepinephrine application, but remained constant in antidepressant groups. In conclusion citalopram and trimipramine affect activity of norepinephrine and resulted in enhanced glycerol release into the circulation. Antidepressant therapy may contribute to weight gain through amplified activity of the sympathetic nervous system.
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The G241R adhesion molecule-1 (ICAM-1) gene polymorphism is associated with||obesity in the Italian population Objective: Two polymorphic variants have been described in the human ICAM-1 gene and have been shown to be significantly associated with several pathologies of inflammatory origin. In this study we evaluated whether these ICAM-1 gene variants are associated with obesity and can influence its protein levels. Methods: Allele-specific PCR and RLFP were used to investigate the presence of G241R and E469K polymorphisms in 237 severely obese subjects (BMI 43±7.2 Kg/m 2 ). One hundred fifty two normal weight individuals (BMI 22.4±2.7 Kg/m 2 ) were also screened as a control group. Results: The G241R genotype distribution was significantly different between obese and control group (P=0.003). Moreover, the frequency of the R allele was 2-fold higher in obese patients compared to control subjects (0.085 vs 0.033, P=0.004; OR, 2.7; 95% CI, 1.3-5.5). When sICAM-1 levels were evaluated according to the G241R genotype, no significant differences were observed. However, as already reported, significant higher sICAM-1 levels were detected in the obese subjects. Finally the allelic frequency of the E469K polymorphism was not different between obese and normal weight subjects.
Conclusions:
To the best of our knowledge, this is the first evidence of an association between the ICAM-1 gene G241R variant and obesity. As this polymorphism does not seem to influence sICAM-1 levels, we can speculate that the presence of the R allele might have a role in the recruitment and activation of immune cells and, thus, might contribute to the low grade inflammatory state present in obese subjects.
T1:PO.64
The CD34+/CD31-progenitor cells of the human adipose tissue: The stroma-vascular fraction of adipose tissue (AT) contains capillary endothelial cells (CECs), inflammatory cells and CD34+/CD31-cells that are able, under appropriate culture conditions, to differentiate into adipocytes or CECs. The present study was performed to analyse the local stimuli involved in the growth and fate of the CD34+/CD31-cells. Mature adipocytes, CECs, CD34+/CD31-cells were isolated from the human subcutaneous AT by an immunoselection/depletion approach as previously described. Conditioned media from freshly harvested adipocytes and CECs were collected. The growth and migratory responsiveness of the CD34+/CD31-cells was determined by BrdU incorporation and Boyden chamber assays, respectively. The CD34+/CD31-differentiation was assessed by the expression of specific adipocyte and CECs markers. CD34+/CD31-cells expressed receptors for adipokines, leptin and adiponectin, growth factors and chemokines. Adipocyte-and CECs-conditioned media induced the proliferation and the migration of the CD34+/CD31-cells. Whereas adipokines had no proliferative effect, several inflammatory cytokines as well as growth factors stimulated the growth of the CD34+/CD31-cells. Migration of CD34+/CD31-cells to conditioned media involved a chemotaxis response mediated through the activation of Gi-coupled receptors. Finally, a medium allowing the differentiation of the CD34+/CD31-cells into adipocytes and CECs was defined. To conclude, the present study strongly suggests that stimuli arising from mature adipocytes and CECs modulate the growth and differentiation of the AT-derived CD34+/CD31-cells. Such local signals might be involved in the control of adipogenesis and vascular network extension and thus in the fat mass development with obesity.
T1:PO.65
Influence of sex hormones on adiponectin expression in human adipocytes Introduction: Adiponectin is an adipocytokine with profound anti-diabetic and anti-atherogenic effects. Plasma adiponectin concentrations are significantly higher in women than in men. In order to study the molecular aspects of this gender specific dimorphism, we examined the expression of adiponectin under the influence of sex hormones. Methods: As a model system we have used human SGBS preadipocytes and adipocytes. Differentiating cells (d 8) as well as mature adipocytes (d 14) were incubated with increasing doses of testosterone (1 -1000 ng/ml) or estradiol (0,1 -100 nM). Adiponectin mRNA expression was determined by RT-PCR using specific primers. Adiponectin secretion into the medium supernatant was measured by ELISA. Results: Adiponectin mRNA expression was up-regulated during adipogenic differentiation. Adiponectin secretion into the culture medium was detected starting at d 7 (~ 50 ng/ml). Neither testosterone nor estradiol treatment had an influence on adiponectin mRNA expression in human adipocytes. Adiponectin expression was unaffected even after long incubation periods for up to 7 days. Preliminary data show that secretion of adiponectin was constant upon treatment with both sex hormones. Further experiments using BMImatched male and female serum samples will provide new insights into regulation of adiponectin expression by systemic humoral factors. Conclusion: Our data suggest that testosterone and estradiol have no direct influence on the expression of adiponectin mRNA in SGBS adipocytes. Thus, we hypothesize the existence of a systemic factor which is regulated by sex hormones and subsequently causes the sexual dimorphism in adiponectin plasma levels. Research relating to this abstract was funded by the Landesforschungsschwerpunkt "Metabolisches Syndrom", Universität Ulm.
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International Journal of Obesity Obesity is a state of chronic low -grade inflammation associated with elevated plasma levels of proinflammatory cytokines (e.g. TNF -α, IL-6), chemokines (e.g. MCP -1) and prothrombotic proteins (e.g. PAI -1), which are in volved in development of obesityrelated diseases such as type 2 diabetes and atherosclerosis. Adipose tissue and in particular also adipocytes are known to produce these so called adipokines, among them the monocytechemoattractant protein -1 (MCP-1). Recent transgenic mouse data implicated MCP-1 in mediating adipo se tissue macrophage infiltration, which may additionally promote the proinflammatory state in obese rodents and humans. In this study, we analysed the regulation of MCP -1 expression in human adipocytes. The human preadipocyte cell line SGBS was stably infected with different proteins interfering dominant negative ly or active ly with the NFkB signalling pathway. Transient transfection of the cells with luciferase reporter constructs, regulated by MCP -1 and IL-6 upstream regulatory sequences w as performed. Furthermore, the regulation of the endogenous genes in stable cells w as analysed by qRT -PCR, and protein secretion into the cell culture medium by ELISA. It could be show n that the MCP -1 and IL-6 gene are regulated by NFkB in human preadipocytes both at the basal expression level and upon TNF-α stimulation. Using this approach, we are currently further analys ing in detail which components of the NFkB pathway are involved in adipokine regulation in human preadipocytes and adipocytes. In conclusion, our data suggest that the NF kB pathway plays a central role in the regulation of the proinflammatory proteins MCP -1 and IL-6 in human adipose tissue. Increased adipose tissue (AT) secretion of adipokines and cytokines has been involved in the chronic low-grade inflammation state and insulin resistance associated with obesity. We tested here whether the cardiovascular and metabolic hormone ANP (atrial natriuretic peptide) was able to modulate AT secretion of several adipokines (derived from adipocytes) and cytokines (derived from AT stromal cells) linked to insulin resistance either directly or through induction of lipolysis. We used protein array to measure the secretion of adipokines and cytokines after 24h culture of human AT explants treated or not with a physiological concentration of ANP. The gene expression profile of the regulated factors was determined by RT-qPCR on total RNA from adipocytes obtained after collagenase digestion and macrophages isolated from the stromavascular fraction by CD14-positive immunoselection. ANP decreased the secretion of the pro-inflammatory cytokines interleukin-6 and tumor necrosis factor-, of many chemokines, and of the adipokine leptin and retinol binding protein 4 (RBP-4). The secretion of the anti-inflammatory molecules interleukin-10 and adiponectin remained unaffected. The cytokines were mainly expressed in macrophages that expressed all components of the ANP-dependent signaling pathway. The adipokines, leptin, adiponectin and RBP-4 were specifically expressed in mature adipocytes. The inhibitory effects of ANP on leptin and growth related oncogene secretions were neutralized under selective hormone sensitive lipase inhibition. These data suggest that ANP down-regulates the secretion of several adipokines, chemokines and cytokines with a role evoked in insulin resistance in humans either directly or through induction of lipolysis.
T1:PO.67
T1:PO.68
Pattern of expression of adiponectin receptors in the liver and its relation to non-alcoholic steatohepatitis Nannipieri In mice with non -alcoholic-steatohepatitis(NASH), adiponectin(APM1) and its receptors are thought to mediate anti -steatosis/anti-inflammatory effects. Our aim was to define APM1 expression in subcutaneous -SAT-and visceral -VAT-adipose tissue and expression of its receptors in the liver (LAPMR1/LAPMR2) in relation to liver histology in morbidly obese patients. Total-RNA was extracted from SAT, VAT and liver tissues obtained during gast ric-bypass from 71 subjects (BMI 47.1±7.6 kg/m 2 ). Relative quantifications of APM1,LAPMR1,LAPMR2 was performed by Real -Time-PCR. Subjects were divided according to liver histology: 7 normal liver[NH]; 43 with steatosis: 23 with NASH. Results were expressed as the target/HPRT ratio. Plasma adiponectin levels were higher in NH than NASH (5.3±2.0 vs 4.8±2.9 vs 3.4±1.2µg/ml, respectively, P=0.05 ). VAT-APM1 was significantly more expressed in NH than NASH (0.74±0.26 vs 0.70±0.53 vs 0.48±0.30, P=0.05). Plama adip onectin was directly related to P<0.004) . In contrast, LAPMR1 was less expressed in NH than NASH (1.05±0.14 vs 1.26±0.33 and 1.44±0.40, P ≤0.02) as was LAPMR2 (0.78±0.28 vs 0.97±0.39 and 1.23±0.47, P ≤0.02). In multivariate model s adjusting for sex, age, and BMI, liver enzymes (AST,ALT,gGT) levels were related to LAPMR1(s.d.r=-0.43,P<0.0005;sd.r=-0.38,P<0.003;s.d.r=-0.32,P<0.02) and LAPMR2 expression (sd.r=-0.31,P<0.01;sd.r=-0.30,P<0.02;sd.r=-0.45,P<0.0002). Furthermore, LAPMR1 and LAPMR2 expression were reciprocally related to plasma adiponectin (r=0. 46,P=0.0016 and r=0.30,P=0.05, respectively) . We conclude that in severely obese subjects NASH is associated with a lower adiponectin levels in plasma and expression in VAT, but with higher expression of its receptors in the liver. The pattern of association suggests that hepatic adiponectin receptors expression is upregulated in the presence of NASH as a compensatory response to hypoadiponectinemia.
T1:PO.69
Pathogenetic factors in obesity contributing to the development of heart failure As a consequence of obesity-related haemodynamic, metabolic and neuroendocrin alterations, left ventricular hypertrophy, diastolic and systolic dysfunction occurs, finally overt congestive heart failure with low ejection fraction develops. The possible correlation of anthropometric and metabolic parameters with structural and functional alterations on echocardiography was studied in 50 obese patients (age:40.65±11 yrs, BMI:39.27±7.36 kg/m 2 ), and 42 non-obese age-and sexmatched normal controls (age:37.29±10.09 yrs, BMI:22.27±1.81 kg/m 2 ). Blood samples were assayed for "routine" laboratory parameters and oxLDL, TBARS, FFA, leptin, adiponectin, resistin, sE-selectin, PON1-activity, NO, TNFα, and IL-6. Correlations between variables were assessed by Spearman correlation. Significant (P≤0.05) correlation was found between adiponectin and the following parameters: HDL-C (r=0.56), ApoA-I (r=0.43), PON1-activity (r=0.23), waist circumference (r=-0.37), insulin (r=-0.40), triglyceride (r=-0.46), and sE-selectin (r =-0.23). sE-selectin correlated with HDL-C (r=-0.33), triglyceride (r=0.25), and diastolic blood pressure (r=0.28). BMI correlated significantly with insulin (r=0.52), HOMAR (r=0.41), HgbA1C (r=0.42), C-peptide (r=0.57), adiponectin (r=-0.49), leptin (r=0.79), and resistin (r=-0.26). Left ventricular mass index correlated significantly with BMI (r=0.39), waist circumference (r=0.49), HgbA1C (r=0.55). Ejection fraction correlated significantly with HDL-C (r=0.33), C-peptide (r=-0.36), and HgbA1C (r=-0.38). Systolic peak velocity of the myocardium was significantly lower in each segment measured by myocardial Doppler imaging in obese patients compared to non-obese subjects. Transmitral E/A and myocardial Doppler imaging data indicated an initial relaxation problem in obesity. In conclusion an early target organ damage can be detected in obese patients, and a correlation exists between metabolic alterations and changes in structural and functional echocardiographic parameters.
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T1:PO.70
Association between endothelial nitric oxide synthase haplotypes, abdominal obesity, and metabolic syndrome Coenzyme Q (CoQ) is an obligatory partner of mitochondrial biology and also the unique lipophilic antioxidant synthesized in humans. Although involved in numerous disorders, no clear link with adipocyte biology has been yet established. Here, we demonstrate that CoQ is specifically depleted in adipose tissue of obese mice and humans. Cotreatment of obese mice with a PPARg agonist and CoQ fully restored adipose tissue CoQ content. Moreover, CoQ treatment not only counteracted adverse side effects classically induced by PPARg ligands but also improved their effects on energy homeostasis. In addition, CoQ content in adipocytes is positively correlated to adiponectin gene expression, a critical regulator of insulin sensitivity, and associated to decreased TNFa gene expression, and thus to a decreased inflammatory state. In vitro, CoQ modulated PPARg activity in an adipose cell and receptor specific manner through SIRT1. As a whole, these data strongly suggest that adipose CoQ behaves as a key factor of adipocyte biology and the development of obesity.
T1:PO.72
Functional analysis of melanocortin-4-receptor (MC4R) mutants: critical role of W174C substitution in the fourth transmembrane domain Introduction: MC4R is involved in obesity and mutations in this receptor account for 4 -5% of all cases of gene tic obesity. We recently genotyped 200 unrelated obese adults (BMI • 40) from Campania (1). We identified 4 novel mutations: two missense mutation s (W174C and I317V) in the IV transmembrane domain and in the C -tail respectively, and two nonsense mutations (Q43X and S19fsX51) resulting in truncated proteins. Here we report the in vitro functional analysis of these muta tions. Methods: MC4R cDNA wild type (wt) and the W174C and I317V mutants were cloned in a pcDNA 3.1/His vector. Receptor activity was assayed by transient transfection of these plasmids in COS -7 cells with 0.1, 1, 10 and 1000 nM of the natural ligand, a-MSH. We identified the membrane localization of wt and mutant receptors in HEK -293 cells using immunofluorescence staining. Competitive binding for receptor/ligand was evaluated by FACS (2). Results: Mutants Q43X and S19fsX51 were inactive, as reported for other truncated proteins. The cell-surface expression of mutant I317V was much lower versus wt MC4R. Mutant W174C has no activity, which is surprising given its proximity to the mutant A175T that exerts partial activity. However, its cellsurface expression resembles that of wt receptor. Mutant W174C had reduced a-MSH affinity (50% vs 100% wt receptor; Scatchard plot), which could explain its reduced activity. 
T1:PO.73
Differential magnitude in the early response of key genes to short-term fasting in soleus and gastrocnemius skeletal muscles Fasting induces metabolic and gene-expression changes in skeletal muscle, and a short term food-deprivation model can help us to uncover the earliest response of key genes. Peroxisome proliferator-activator receptor gamma coactivator-1 alpha (PGC-1α) induces and coordinates gene expression stimulating events as mitochondrial biogenesis, fibre type switching and specific type I fibre gene expression. Uncoupling protein 3 (UCP3) has been involved in limiting ROS formation and the handling of lipids as fuel substrate. We aimed to characterize the response of PGC-1α and UCP3 mRNA expression under short-term fasting in a mixed fibre type muscle (gastrocnemius) with a high capacity to shift between glucose and lipids as fuel substrate and in a muscle rich in slow twitch oxidative fibres (soleus). Five different feeding conditions were studied in adult male Wistar rats: ad libitum feeding (control group), 4, 8 and 24-hour fasting, and 3-hour refeeding after 8-hour fasting (re-fed group). PGC-1α and UCP3 mRNA levels were analysed by RTqPCR. As expected, fasting caused a significant increase in UCP3 mRNA levels in muscle, with a more pronounced rise in the gastrocnemius than in the soleus, returning to control levels in the re-fed group. PGC-1α mRNA expression tended to be increased after 4-hour fasting, also more markedly and significantly in the gastrocnemius, afterwards returning to control levels in both muscles at 8-hour fasting. The results show that pgc-1 and ucp3 are early response genes to fasting in skeletal muscle, being its response related to its role in the metabolic shift from glucose to lipid use as fuel.
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Tissue specific modulation of AMPK phosphorylation in high-fat diet-fed rats treated with 3,5-diiodothyronine (T2) is related to fatty acid demand Università Degli Studi del Sannio, Benevento, Italy 3,5-diiodo-L-thyronine (T2) is able to prevent body weight-gain and fat accumulation when administered to rats receiving a high -fat diet (HFD). It induces an increase in fatty acid (FA) oxidation concomitant to their less efficient utilization. The effects of T2 on fatty acid oxidation involve the AMP-activated protein kinase (AMPK), but it is not clear how its modulation is achieved in tissues such as liver and white adipose tissue (WAT). Six groups of rats were used, either receiving a 1 -week HFD or a 4-week HFD, with or without a daily i.p. injection of T2 (25 mg/100 g BW), or a standard diet for 1 or 4 weeks (N). After 7 days, liver AMPK phosphorylation is decreased in both HFD and HFD-T2-treated rats with respect to N ones whereas after 30 days the HFD -T2-treated rats show a marked increase in liver AMPK phosphorylation. This transient variation in the HFD -T2-treated rats is correlated with the hepatic lipid content which is high after 7 days of treatment and almost absent after 30 days. In WAT, after 30 days, the opposite is true: HFD-T2-treated rats show a marked decrease in AMPK phosphorylation with respect to HFD controls and to N rats. This variation is associated with an increased release of FA by WAT as deduced by its reduced mass. In conclusion, treatment with T2, by increasing FA utilization, results in differential, transient AMPK phosphorylation between a tissue which depends on FA usage (the liver) and one that causes their release (WAT). Variants in both genes have been associated with features of metabolic syndrome (MS). To determine whether the Gly482Ser polymorphism of the PGC-1 gene was associated with features of MS in the Spanish population and its interaction with the Pro12Ala PPARG polymorphism, we genotyped 806 unrelated subjects recruited from a crosssectional population-based epidemiological survey in Central Spain (Segovia, Castille). BMI, WHR. OGTT, fasting and 2 hrs glucose, serum insulin, leptin, adiponectin levels; lipid profile. Insulin resistance by HOMA-IR. Gly482Ser PPARGC1 and Pro12Ala PPARG genotypes determined by PCR-RFLP. MS (2005 IDF criteria). In the whole population the Gly482Gly genotype was associated with higher WHR (0.911.03 vs. 0.890.09, P=0.035), and a trend toward higher IR (P=0.076) compared with Ser482 allele carriers. Among non-obese the presence of MS was higher in those with the Gly482Gly than in Ser482 allele carriers (21.5% vs. 14.4%, P=0.032). Impaired glucose tolerance was higher in Pro12Pro homozygous compared to carriers of the Ala12 allele (16.8% vs 8.1%, P=0.027) even after adjustment for sex, age, BMI, WHR and IR (OR: 2.5, CI 95% 1. 04-6.25, P=0.049 ). An additive effect between Gly482Gly PPARGC1 and Pro12Pro PPARG genotypes, and a higher presence of MS was detected in non-obese subjects, suggesting a genegene collaboration. Gly482Gly PPARGC1 variant per se might favour predisposition to abdominal obesity and insulin resistance in our population. A possible additive effect between Gly482Gly PPARGC1 and Pro12Pro PPARG genotypes on the presence of MS in non-obese individuals is suggested.
T1:PO.76
Association between genotypes and specific phenotypes of obesity -A comparison of ten specific obesity phenotypes Background: The detrimental effects of obesity depend on the body fat dist ribution, which may signify possible etiological heterogeneity as well. Previous association studies on single nucleotide polymorphisms (SNPs) for UCP2, UCP3, PPAR g, CART, GRL, MC4R, PTP1B, MKKS, SHP, IRS1, GHRL, MCHR1 and obesity have mainly focused on BMI, but with inconsistent results. Objective: We systematically examined and compared eleven specific abdominal, peripheral, and overall obesity phenotypes with previously published S NPs in the mentioned panel of obesity candidate -genes. Methods: Analyses were performed using anthropometric and genotype data from a follow -up examination in 1998 -2000 of a population-based case-cohort study of obese men (n=234; BMI•31 kg/m 2 ) and a control group (n=323; BMI<31 kg/m 2 ). Obesity phenotypes included BMI, fat mass (FM), waist, waist|BMI, waist|FM, intraabdominal adipose tissue, sagittal abdominal diameter, hip, hip|waist, and lower body fat. Associations between SNPs and obesity phenotypes were analyzed separately in codominant, dominant and recessive genetic models. Results: The minor allele for SHP G171A was associated with large hip in a dominant model (P=0.02). The major allele for UCP2 -866G>A and MKKS Arg51Cys was associated with increase d visceral (P=0.01) and overall obesity (P=0.05) in a recessive model. The minor allele for IRS1 G972R and MCHR1 100213G>A was associated with little visceral obesity in a dominant model (P=0.003 and P=0.02-0.05, respectively). The major allele for UCP2 exon8 was associated with little v isceral (P=0.01-0.04) and overall obesity (P=0.003-0.04) in a recessive model. Conclusion: We found distinct associations between gene polymorphisms and specific obesity phenotypes, predicting beneficial or detrimental effects, depending on abdominal, peripheral or overall obesity.
T1:PO.77
Relationship of circulating levels and adipose tissue expression of Adiponectin with insulin-resistance in severe obesity Severe obesity is associated with muscle insulin-resistance and reduced circulating adiponectin concentrations. We investigated whether other tissues (liver and fat) also are insulin-resistant and whether such insulin-resistance is associated with reduced plasma adiponectin and adiponectin gene expression in visceral (VAT) and subcutaneous (SAT) adipose depots. Eleven severely obese non-diabetic women (OB, BMI=51±2kg/m 2 ) and 7 lean women (CT, 23±1kg/m 2 ) received a euglycaemic-hyperinsulinemic clamp with measurement of endogenous glucose production (EGP, by 6,6-2H2-glucose) and lipolysis (as release of glycerol, RaGLY, by 5H-glycerol). Hepatic resistance (H-IR) was expressed as EGPxFasting Insulin and adipose tissue insulin-resistance (AT-IR) as RaGLYxFasting Insulin. Adiponectin expression in VAT (APNVAT) and SAT (APNSAT) was measured by Real-Time PCR in tissue specimens obtained during bariatric surgery (gastric by-pass) in 8 obese subjects. Compared to CT, OB were more insulin-resistant at the whole-body level (M value:33±5 vs 59±8µmol. Plasma adiponectin levels were decreased in OB (5±1vs8±1ng/ml, P=0.02) and were inversely related to H-IR (r=-0.59, P=0.01), P=0.02), P=0.04) and directly related to M values (r=0.77, P=0.0003) . In OB, APNVAT expression, but not APNSAT, was directly related to plasma adiponectin (r=0.78, P=0.03) and M (r=0.88, P=0.004 ). In conclusion, in morbidly obese subjects insulin-resistance is present at all levels (muscle, liver and adipose tissue) and is associated with decreased levels of circulating adiponectin. Plasma adiponectin is the principal determinant of peripheral insulinsensitivity. Reduced adiponectin expression in visceral, but not subcutaneous, fat is associated with peripheral insulin-resistance.
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International Journal of Obesity BACKGROUND: Extracellular nucleotides have been identified as important signaling molecules regulating physiological functions almost in all cells acting on specific plasma membrane receptors named P2 purinergic (P2R). These receptors can f orm ion-channels or activate a signal transduction pathway via G -protein involvement. Obesity is a chronic low grade inflammatory condition associated with an abnormal cytokine production and increased macrophage infiltration. Although a role of P2R in inflammation has been highlighted, the expression pattern of these receptors in different adipose tissue depots and in adipocyte cultures has not been studied. The aim of the present study was to investigate the role of the purinergic system in adipose tissue. METHODS: RT -PCR was utilized to detect the expression of the different P2R subtypes in visceral and subcutaneous adipose tissue from healthy and obese subjects. P2R expression profile was analyzed during in vitro adipogenic differentiation. Cytokine secretion was detected with immunoenzymatic assay. ATP released from cell cultures was measured by luminescent assay.
RESULTS:
We identified almost all subtypes of P2R in human adipose tissue. Interestingly only two were differently expressed in preadipocytes and in mature adipocytes, both in vitro and ex vivo. Human adipocytes secreted IL -6 after stimulation with extracellular ATP in a dose dependent manner. Furthermore we revealed that human adipocytes were able to tonically release ATP.
DISCUSSION:
The results of the present study show that the purinergic system is present in fat cells and could be involved in the mechanisms modulating the inflammatory response in obesity.
T1:PO.79
Postnatal development of Zinc-alpha2-glycoprotein expression in rat adipose tissue Tzanavari Theodora 1 , Bing Chen 1 , Trayhurn Paul 1 1 University Of Liverpool, United Kingdom BACKGROUND: Extracellular nucleotides have been identified as important signaling molecules regulating physiological functions almost in all cells acting on specific plasma membrane receptors named P2 purinergic (P2R). These receptors can form ion-channels or activate a signal transduction pathway via G -protein involvement. Obesity is a chronic low grade inflammatory condition associated with an abnormal cytokine production and increased macrophage infiltration. Although a role of P2R in inflammation has been highlighted, the expression pattern of these receptors in different adipose tissue depots and in adipocyte cultures has not been studied. The aim of the present study was to investigate the role of the purinergic system in adipose tissue. METHODS: RT -PCR was utilized to detect the expression of the different P2R subtypes in visceral and subcutaneous adipose tissue from healthy and obese subjects. P2R expression profile was analyzed during in vitro adipogenic differentiation. Cytokine secretion was detected with immunoenzymatic assay. ATP released from cell cultures was measured by luminescent assay.
RESULTS:
DISCUSSION:
T1:PO.80
Mechanism of leptin expression in breast cancer cells: Role of hypoxiainducible factor-1alpha
Surmacz Eva 1 , Cascio Sandra 1,2 , Bartella Viviana 1,3 , Auriemma Alessandra 1,4 , Russo Antonio 1,2 , Giordano Antonio
We reported previously that the obesity hormone leptin is overexpressed in breast cancer biopsies. Here we investigated molecular mechanisms involved in this process. We found that the leptin promoter is activated by high doses of insulin and/or hypoxia, conditions that are associated with obesity. These treatments also increased nuclear accumulation of hypoxia-inducible factor 1α (HIF-1α). In breast cancer cells, HIF-1α associated with upstream leptin gene regulatory sequences, especially with the proximal promoter containing four hypoxia response elements and three GC-rich regions. Loading of HIF-1α to the proximal leptin promoter coincided with corecruitment of p300, the major HIF coactivator. Association of HIF-1α/p300 with the leptin promoter was followed by increased leptin mRNA and protein expression. Conversely, downregulation of HIF-1α with RNA interference totally abolished leptin expression. The highest levels of nuclear HIF-1α, the greatest association of HIF-1α/p300 with the proximal leptin promoter, and the maximal leptin mRNA and protein expression were induced by combined insulin and hypoxia treatments. Our results suggest that targeting HIF-1α might be essential in the treatment of leptin-overexpressing breast tumors. Research relating to this abstract was funded by the WW Smith Charitable Trust and Sbarro Health Research Organization.
T1:PO.81
Regional differences in the response of adipose tissue to short-term food deprivation in the rat The adipose tissue undergoes important adaptations during fasting; however differences in metabolic activity of adipocytes exist depending on the localization of the tissue. Thus, we have studied the effect of short-term food deprivation on the expression of genes involved in lipid metabolism in adipose tissue from different anatomical localization in the rat. We studied adult male Wistar rats under feeding conditions, and after 4-, 8-or 24-h fasting, and analysed by RT-qPCR the expression of genes involved in lipogenesis (FAS, ACC1, GPAT), lipolysis (CPT-1), PPAR-gamma, and GLUT-4 in subcutaneous (inguinal) and in visceral (retroperitoneal and mesenteric) white adipose tissue depots. Fasting induced a decrease in the size of fat depots that was higher for the retroperitoneal depot, followed by the mesenteric and finally by the inguinal depot. In the different fat pads, fasting was accompanied by a decreased rate of fat synthesis, as evidenced by a decrease (after 8-h fasting) in the expression of lipogenic enzymes. However, mRNA levels of CPT-1 increased after 24-h fasting in the retroperitoneal and mesenteric fat depots, while decreased in the inguinal depot. This was parallel to a decrease in PPARgamma expression levels (already after 4-h fasting) in the retroperitoneal depot and of GLUT-4 (after 8-h fasting) in the retroperitoneal and mesenteric depots, while the expression of these genes was not significantly changed in the inguinal depot. In summary, these results agree with different functionally and metabolic activity between subcutaneous and visceral adipose tissues (the latter more oxidative) that are further enhanced during starvation.
The metabolic syndrome is associated with an increased risk of developing cardiovascular disease, and PAI-1 overexpression may participate in this process. The positive correlation b etween PAI-1 adipose tissue gene expression and serum concentration has been observed. Increased PAI -1 blood levels enhance the risk of atherothrombosis. It has been shown in obese children high serum levels of thyroid hormones (T3 and T4) and PAI -1. The aim of this study was to analyse the effect of T3 and T4 treatment on PAI -1 gene expression by 3T3-L1 adipocytes. Cells were treated with T3 or T4 (10 or 100nM) for 24 o r 48 hours. Cells were harvested and RNA extracted with Trizol. PAI-1 mRNA quantificatio n was performed with Real Time PCR. The 24 hours treatment with 100nM T3 increased the PAI -1 mRNA as compared to the control (241,61 ± 30,2 vs. 100,51 ± 10,9). The same was observed on the 48 hours treatment with 10nM T4 (289,5 ± 46,0 vs. 100,0 ± 5,5) . The se results show that thyroid hormones stimulate PAI-1 adipose tissue gene expression in cultured cells, and it may be suggested that there is a pos itive correlation between PAI-1 blood levels and thyroid hormone s in human beings. Supported by FAPESP and CN Pq.
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International Journal of Obesity The nutritional status of the mother during gestation and early lactation may affect fatty acid metabolism in the o offspring. Fatty acid transport proteins (FATP) play an important role in the cellular uptake of fatty acids. In this research we studied the impact of maternal diet on mRNA expression levels of FATP4 in the intestine and FATP1 in adipose tissue. Three groups of female Wistar rats (n=28 -32) were kept on a control diet (C), a high fat/high calorie (H) or a restricted/ low calorie (L) diet during 6 weeks premating, mating, gestation and lactation. Immediately after birth (postnatal day (PN) 1), F1 -pups were cross-fostered to dams of the same group or to dams of the other two dietary groups resulting in 9 different groups and fed the various diets up to PN 70. At PN01 and PN70 animals were sacrificed and FATP4 and FATP1 mRNA expression levels determined. Food consumption, energy intake and body weight of the dams differed significantly between the groups . The results showed that 1) at birth, pups of dams on a high and low calorie diet showed higher FATP4 and lower FATP1 levels as compared to the controls 2) apparently, FATP4 expression levels in the intestine decreased from birth onwards to PN 70 3) Differences in FATP4 and FATP1 expression levels were larger in male than in female offspring 4) Differences in maternal diet affected both FATP4 and FATP1 expression levels in intestine and adipose tissue, respectively. In conclusion, maternal diet manipulation affects FATP1 and FATP4 expression levels in the offspring.
T1:PO.87
Arachidate induces hypothalamic inflammation through mechanisms dependent on TLR2 and TLR4 activation and endoplasmic reticulum stress -20:30:30:20) . Highest expressions of the pro -inflammatory cytokines TNF -, IL-1, IL-6 were observed after five days treatment with the saturated fat mixture. To further explore the role individual saturated fatty acids in the induction of hypothalamic inflammation, rats were icv treated with each of the saturated fatty acids. Highest expression of inflammatory cytokines was detected with arachidate. To explore the mechanisms involved in arachidate -dependent induction of inflammatory response in hypothalamus, icv cannulated rats were treated with arachidate and samples of hypothalami were obtained after 0 -5 days for evaluation of induction of endoplasmic reticulum stress (GRP78, phospho -elf2a, phospho -PERK and phospho -JNK) and activation of T LR2 and TLR4 signaling (association of TLRs with Myd88). Both, the induction of endoplasmic reticulum stress and the activation of TLR2 and TLR4 signaling were detected after 3 days of icv arachidate treatment. Thus, arachidate appears as an important hypo thalamic pro-inflammatory factor that may play a role in diet -induced resistance to anorexigenic signals.
T1:PO.88
Characterization of the transcriptional control of the human CIDEA gene Background: Obesity and peripheral insulin resistance are risk f actors for development of non-insulin dependent diabetes mellitus (NIDDM) but the molecular mechanisms underlying the association remains to be defined. We recently described a gene, cell death-inducing DFFA (DNA fragmentation factor -a)-like effector A (CIDEA) with important effects on human adipocytes and with a possible protective role in insulin resistance. CIDEA mRNA expression in adipose tissue is reduced in obesity and correlates negatively with features of the metabolic syndrome. Both in vitro and in vivo data suggest that downregulation of CIDEA may be important for the development o f insulin resistance. The transcriptional regulation of CIDEA in human cells is unknown. Aims: To investigate the transcriptional regulation of human CIDEA. Methods: A 1340bp genomic fragment upstream of the transcriptional start site was cloned. Fragments of different size were generated and inserted into the luciferase reporter vector pGL3-basic. Transcriptional activity of promoter constructs was analysed in 3T3 -L1 cells. Results: Bioinformatic analysis of the 1.34kb sequence revealed a number of putative transcription factor binding sites. There was an inverse relationship between luciferase activity and the length of the fragments suggesting that inhibitory regions may be present in the region -1340-500bp. Detailed analysis of multiple single nucleotide polymorphisms and corresponding haplotypes in the promoter are now under way. Conclusion: We were able to define the minimal promoter required for CIDEA transcription in a 1.34kb long sequence upstream of transcription start site of the CIDEA gene. These results are important for future modulatory effects on C IDEA expression.
T1:PO.89
Association of TNF-a -308 G>A polymorphism with obesity and lifestyle parameters in children 10-12 years Several studies have suggested an association between Tumor necrosis factor -alpha -308 G>A polymorphism (TNF -a) and obesity related phenotypes. Moreover, there are environmental factors, such as eating frequency (EF) and physical activity that have also been found to influence obesity status. Aim of the present study was to evaluate possible interactions between TNF -a -308 G>A polymorphism, obesity and lifestyle parameters in a randomly selected group of children 10 -12 yrs, who enrolled in the Gene -Diet Attica Investigation on childhood obesity (GENDAI). These children underwent full nutritional assessment and biochemical measurements. For the present study, the above -mentioned associations were evaluated in a subsample of 472 children. Genotyping was performed by PCR-RFLP analysis. The genotype frequencies were 85% (n=401), 14.8% (n=70) and 0.2% (n=1) for G/G, G/A, and A/A respectively. T he distribution of TNF-a -308 G>A polymorphism did not differ between normal weight, overweight and obese children. Body Mass Index (BMI) was positively correlated with duration of inactivity (minutes) in GA subjects (Spearman rho =0.302, P = 0.012), while no correlation was found for GG subjects. BMI was negatively correlated with EF only in GG subjects (rho= -0.202 in GG subjects, p<0.001 vs. rho = 0.013, P=0.9 in GA subjects). Univariate analysis revealed an interaction between TNF -a -308 G>A polymorphism and EF as well as between TNF-a -308 G>A polymorphism and inactivity, after controlling for potential confounders. In conclusion, these preliminary results indicate that TNF -a-308 G>A polymorphism may be associated with lifestyle parameters and could, thus, influence obesity related phenotypes.
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International Journal of Obesity Many studies performed in adults have reported the implication of genetic determinants in the occurrence and the progression of arterial alterations. To date, no study evaluated this association in children. The aim of the study was to search for genetic markers susceptible to favor the occurrence of early arterial alterations in obese children. Subjects and methods: 232 obese children (150 girls; 11.4 ± 3.1 years; BMI z-score 4.6 ± 1.2 SD) have been studied. We performed an association study between arterial parameters and polymorphisms in genes coding for protein involved in the renin-angiotensin system (angiotensin I-converting enzyme (ACE I/D), angiotensinogen (AGT G-6A and Met235Thr) and angiotensin II type1 receptor (AGTR1 A1166C)); vascular endothelial cell remodelling (Stromelysin 1 (MMP3 5T/6T), plasminogen-activator inhibitor type1 (PAI-1 4G-668/5G), communication (connexin CX37 Pro319Ser) and inflammation through leukocyte adhesion (fractalkine receptor (CX3CR1 Val249Ile); arterial vasodilation (NOS3 Glu298Asp); adiponectin plasma levels (APM1 C-11377G and A-11391G) and lipoprotein metabolism (Paraoxonase 1 (PON1 Glu192Arg). Nonivasive arterial measurements were performed to evaluate the intima-media thickness, the common carotid artery compliance (CCA) and distensibility (CCD), the incremental elastic modulus (Einc), and the endothelial function. Results: among all the polymorphisms studied, only a trends of association between the C allele (additive model) of the angiotensin II type1 receptor and CCA (P=0.13), CCD (P=0.09) and Einc (P=0.07) was observed. Conclusion: these results suggest the AGTR1 A1166C may be involved in obese children early arterial alterations. The replication of this study in a larger cohort is necessary to confirm our result.
T1:PO.91
Association between Glutamate Decarboxylase 2 (GAD2) and binge eating in obese children: results from the GENDAI study There is limited evidence on the role of gene tic and environmental factors on the etiology of childhood obesity, a major health problem worldwide. Recently, polymorphisms in the Glutamic Acid Decarboxylase 2 Gene (GAD2) and specifically the functional -243A>G polymorphism in the 5′ promoter region has been associated with adult morbid obesity and childhood obesity. The Gene -Diet Attica Investigation on childhood obesity (GENDAI) is a school -based crosssectional study. It evaluates the contributions and pivotal interactions of genetic, dietary and physical activity variables on children's overweight. Anthropometric, clinical genetic, socio -demographic, other lifestyle characteristics were collected from participating children. A full dietary assessment w as obtained including a questionnaire on meal patterns and behaviors related to the act of eating, including binge eating behavior. Potential associations between GAD2 polymorphism and binge eating were evaluated in a subsample of 920 children. No association was found between GAD2 (-243A>G) and obesity status (normal weight, overweight and obesity) in children. With regards to binge eating, no association was found between GAD2 and binge eating in normal weight children, while in overweight/obese children a trend towards binge eating (P=0.076) was found in the G allele carriers with 42.9% of GG obese/overweight carriers vs. 21.8% of AA obese/overweight carriers reporting binge eating phenotype. When the two sexes were examined separately, this trend was found only in overweight/obese boys (P=0.073) but not in overweight/obese girls (P=0.673). These preliminary data indicate that GAD2 may play a role in the complex mechanisms underlying energy balance and food intake in overweight children. No conflict of interest Research relating to this abstract was funded by COCA-COLA HELLAS
T1:PO.92
SNPs in adipokines -adiponectin and leptin -as risk factors for diabetic complications: evidence for a "double-hit" mechanism? Diabetic angiopathy is now recognized as an inflammatory process of the vessel wall. Type 2 diabetes (T2DM) is far the most common type frequently accompanied by obesity in affected subjects. Co -occurrence of both diseases is not just an epidemiological association but a likely consequence of common ethiopathogenesis. Adipokines too play multiple roles in inflammation ultimately activating, similarly to hyperglycemia itself, transcription factor NF kB with subsequent inflammatory changes in vascular tissue. Leptin (LEP) and adiponectin (APM1) are, apart of their role in energy homeostasis, examples of vascular proand anti-inflammatory mediators, respectively. Genetic variability in the APM1 and LEP genes could not only modulate the risk of obesity and/or T2DM but also influence susceptibility to the development of diabetic complications. The aim was (i) to analyse association between common functional SNPs APM1 94T/G and LEP -2548G/A with diabetic nephropathy in the pilot study and (ii) using additional more densely spaced SNPs in both genes to ascertain event. haplotype association (ongoing). The cross-sectional study comprised 331 T2DM patients with normoalbuminuria (n=146, age 59.5±14.6 yrs) or diabetic nephropathy (n=185, age 65 .2±14.6 yrs). Genotypes of APM1 94T/G and LEP -2548G/A were detected by PCR -based methodology. SCD1 is a central lipogenic enzyme which catalyses the desaturation of longchain fatty acids and its predominant sites of expression are adipose tissue (AT) and liver. In liver SCD1 has been shown to be repressed by leptin. The role of SCD1 in modulating lipid and glucose metabolism in AT is not clear. The aim was to examine SCD1 gene expression in AT in obese subjects. Seventy-five (37 males, 38 females) obese subjects (60±7 yrs, BMI 32.9±2.8 kg/m 2 , mean±SD) with IGT and features of metabolic syndrome, were recruited. Fasting blood samples were drawn to determine concentrations of plasma glucose, insulin, total lipids and inflammatory markers. SCD1 mRNA expression was studied in abdominal subcutaneous AT using real-time PCR. Gender difference in SCD1 mRNA expression was evident (P=0.004) with 84±31 AU in women and 54±50 AU in men. In the whole study population a positive correlation between SCD1 mRNA levels and percentage of body fat (r=0.447, P<0.001) and body fat mass (r=0.320, P=0.007) was found. In addition, positive correlations, independent of BMI and gender, were found with sterol regulatory element binding protein (SREBP) -1c (r=0.376, P=0.002) and leptin mRNA levels (r=0.345, P=0.004) and with fS-leptin (r=0.260, P=0.034). In women, serum CRP and SCD1 gene expression correlated r=0. 457 (P=0.006) . This is the first study to demonstrate a clear gender difference in SCD1 ene expression women showing higher mRNA levels. The found associations suggest a role for SCD1 in the development or consequences of obesity, but also in the regulation of adipose tissue metabolism. Background: PKA dependent induction of PGC -1alpha and UCP1 expression is an essential step in the commitment of pread ipocytes to the brown adipose tissue (BAT) lineage. In HIB1B (BAT) cells PGC -1alpha and UCP-1 expression is cAMP-inducible, but in 3T3 -L1(WAT) cells, expression is cAMP -insensitive. Our aim was to characterize the proximal CRE in the PGC -1alpha promoter and identify whether the cell -specific differential expression is due to different combinations of transcriptional factors binding to the CRE in response to the cAMP stimulation in BAT and WAT cell lines. Methods: Nuclear extracts were prepared from conflue nt HIB-1B and 3T3-L1 cells treated with forskolin to stimulate cAMP. Nuclear protein binding to the CRE region in the proximal PGC -1alpha promoter was then determined using electromobility shift assays and chrom atin immunoprecipitation experiments .
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Results: Gel shift experiments demonstrated that CREB, ATF -2, C/EBPbeta but not C/EBPalpha, bound to the CRE region in nuclear extracts from HIB -1B cells, but only CREB from 3T3 -L1 nuclear extracts was able to bind on the same CRE. Chromatin immunoprecipitation studies demonstrated that C/EBPbeta and phosphoCREB bound to the CRE region in HIB-1B cells but binding of these transcriptional factors was much less in 3T3 -L1 cells. Adipokines interleukin -6 (IL-6) and leptin are often reciprocally regulated, with IL -6 release greater in visceral and leptin from sub -cutaneous white adipose tissue (WAT). The mechanism of such regulation is unclear. We show that cyclooxygenase-2 (COX-2) is constitutively expressed in WAT and COX-2 inhibition, pharmacologically (aspirin: 5 mM or NS -39 : 1 µM) or using tissue from COX-2 deficient mice, reduces IL -6 levels in visce ral tissue. Furthermore, prostacyclin synthase (PGI2S) expression and activity were higher in visceral WAT a nd levels of a prostacyclin metabolite, 6 -keto PGF1-alpha correlated directly with IL -6 and inversely with leptin release. No depot specific difference in p rostaglandin E2 synthase (PGE2S) activity was evident in WAT and neither adipokine showed significan t association with endogenous PGE2 release. Basal adipose IL -6 secretion was independent of changes in intracellular [Ca2+] but sensitive to elevation in intracellular cAMP acting via the prostacyclin (IP) receptor. Mice on a high -fat diet showed reduced l ocal PGI2S activity and IL-6 release and elevated leptin production. However, whole body IL -6 release increased as a result of increased total body fat mass. In conclusion, depot specific differences in IL -6 and leptin release reflect differences in the activity of COX/prostaglandins axis and represent a suitable target for modulation of adipokines. Research relating to this abstract was funded by the Wellcome Trust, Grant Number 070521/Z/03/Z.
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Introduction: Obesity, insulin intolerance, hypertension, dyslipidemia and hyperleptinemia, hipoadiponectinemia are the main clinical symptoms of metabolic syndrome leading to lipid disorders, atherosclerosis, diabetes associated with pathological angiogenesis. Aim of the study: Was to define the possible link between metabolic syndrome biochemical parameters and angiogenesis. Methods: Three kinds of mice (NZO, NZO/SJL and lhepatocyte RXRα-/-) predisposed to develop parameters of human metabolic syndrome was used. Mice were fed with standard and high fat diet for seven weeks. Weight as well as biochemical serum parameters (glucose, triglycerides, cholesterol, insulin, leptin and adiponectin) were monitored once a week. For angiogenic properties animals were injected subcutaneously with 500•l of matrigel containing (25nM) bFGF at the beginning of the last week of feeding. After six days matrigel plugs were analyzed by immunostaining with the anti-CD31 (PECAM) antibody. The amount of PECAM positive cells, and number of capillaries was counted. Results: High fat diet increased the mice body weight, serum concentration of glucose, cholesterol, insulin and leptin. Some tendency to decrease adiponectin concentration in serum was observed. Analysis of the angiogenesis parameters in matrigel sections revealed tendency for high fat diet to rise number of vessels with and without lumen as well as infiltrated CD31 (PECAM) positive cells. Angiogenic response was observed especially in the NZO mice. Conclusions: Feeding with high fat diet resulted in elevation of parameters characteristic for human metabolic syndrome, increase of the leptin to adiponectin ratio. Aim: To study the effect of exercise training on plasma fatty acid composition (C18:1/C18:0) to estimate SCD -1 activity in the liver in response to a high carbohydrate diet (CHO). Methods: Two groups of rats were either treadmill -trained (TR) for 8 weeks or kept sedentary (Sed). Animals were starved for 24 h, refed a stand ard diet (SD) for 24 h, starved for another 24 h and then refed either a SD or a high CHO diet 24 h prior to sacrifice. Body weight (BW), intra -abdominal fat pad weights, plasma ratio of 18:1/18:0 (desaturation index), liver triglyceride content (TAG), and plasma free f atty acid levels (FFA) were measured in all rats. Results: The high CHO diet resulted in higher (P < 0.05) liver TAG, plasma FFA, and desaturation index compare to the SD diet suggesting an increased hepatic lipogenesis activity. Fat pad weights were lower (P < 0.05) in TR compared to Sed rats. Liver TAG were similar between TR and Sed rats whereas plasma FFA levels were lower (P < 0.01) in TR rats. Training was associated with higher 18:1/18:0 ratio (P < 0.01) in both d iets, but especially when refed the high CHO diet.
Conclusions:
The present data confirm the effects of exercise training on body composition. The increase in the desaturation index suggests an upregulation of hepatic SCD-1 activity with training. The absence of effect of training in liver TAG accumulation in presence of an increased SCD -1 activity suggests a higher VLDL production as an adaptation to exercise training. Supported by grants from NSERC and CIHR
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PPARgamma antagonist GW9662 modulates specifically PPARgamma2 expression to abrogate differentiation of primary human preadipocyte Leyvraz Céline 1 , Suter Michel, Verdumo Chantal, Calmes Jean-Marie, Paroz Alexandre, Gaillard Rolf C, Pralong François P, Giusti Vittorio 1 Service Of Endocrinology/ CHUV Background: Rosiglitazone (RTZ) treatment enhances insulin sensitivity by activating PPAR (peroxisome proliferator and activated receptors γ) isoforms. This is accompanied by a remodelling of the adipose tissue (AT) and an increase in fat storage. We hypothesized that RTZ acts more specifically on PPARγ 2 isoform. In order to investigate the role of PPARγ 1 and PPARγ 2 during preadipocyte differentiation into mature cells capable of lipid storage, we analysed primary human preadipocytes treated with PPAR antagonist GW9662. Methods: Preadipocytes were derived from subcutaneous and visceral biopsies of AT obtained from obese women (mean of BMI of 43±1.5 kg/m 2 (range 39.7-54.8)) during gastric by-pass surgery. Subsequently, cells were treated with serum-free medium containing dexamethasone and RTZ (DR) and supplemented or not with GW9662. They were then used to perform oil-red O staining and gene expression measurements by realtime RT-PCR (LightCycler®technology). Results: DR treatment induces preadipocyte differentiation by enhancing PPARγ 1 and PPARγ 2 gene expression. Interestingly, GW9662 is able to prevent gene expression of mature adipocyte markers (ap2, LPL and leptin) and lipid droplet accumulation in preadipocytes of subcutaneous and visceral origin. Concomitantly, GW9662 inhibits the DR-dependent increase of PPARγ 2 expression in both SAT and VAT (by 97% and 92% respectively, P<0.001; n=7). However, it has no significant effect on PPARγ 1 expression (SAT: -55%, P=0.08; VAT: +10%, P=0.56; n=7). Conclusions: GW9662 treatment abrogated RTZ-induced preadipocyte differentiation and lipid accumulation by inhibiting PPARγ 2 gene expression, but it did not change PPARγ 1 gene expression. These results suggest that PPARγ 2 might be the main isoform implicated in fat storage.
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Normal Weight Obese syndrome: role of single nucleotide polymorphism of IL-15R and MTHFR 677C->T genes in the relationship between body composition and resting metabolic rate We have identified a subset of metabolically obese, but normal weight individuals, with potentially increased risks of developing the metabolic syndrome, despite their normal body mass index. We determined the relationship among body fat distribution, resting metabolic rate (RMR), total body water amount (%TBW), selected gene polymorphism on interleukin-15 receptor-alpha (IL-15R) and methylenetetrahydrofolate reductase 677CT MTHFR 677CT, to distinguish normal weight obese (NWO) from nonobese with a normal metabolic profile and obese individuals. We analysed anthropometric variables, body composition by Dual energy X-ray Absorptiometry (DXA), RMR by indirect calorimetry, %TBW by bioimpedence analysis (BIA), MTHFR 677CT and IL-15Rα genotypes of 128 clinically healthy Caucasian individuals. We compared a group of female, defined as NWO and characterised by a BMI ≤25 kg/m 2 and FM 30% with groups of others female, and males, represented by nonobese with a BMI ≤25 kg/m 2 and FM 30%, and preobese-obese individuals with BMI ≤25 kg/m 2 and %FM 30%; none of the males was classified as NWO. Significant correlations were found among body fat mass distribution, metabolic variables, percentage of total body water distribution and selected genetic variations. The variables that contributed significantly to the separation of classes were body tissue (Tissue), %TBW, RMR, the volumes of both oxygen (VO2) and carbon dioxide (VCO2). The distribution of MTHFR677CT and IL-15 genotypes was significantly different between classes. Our data highlight that NWO individuals showed a significant relationship between the decrease in the basal metabolism (RMR), body fat mass increasing and total water amount. Possession of wild type homozygotes genotypes regarding IL-15 cytokine and MTHFR enzyme characterised NWO individuals.
T1:PO.109
In spite of low contribution of white adipose tissue (WAT) to wholebody energy expenditure, respiratory uncoupling in WAT mitochondria by ectopic expression of mitochondrial uncoupling protein 1 (UCP1) protected transgenic mice (aP2-Ucp1 mice) against obesity (Kopecky et al, JCI, 1995) . In this report, we studied the effect of respiratory uncoupling in WAT on whole body energy expenditure. Adult aP2-Ucp1 mice and their nontransgenic littermates on C57BL/6J background fed chow diet ad libitum and maintained at 30 o C were used. Whole body O 2 consumption, CO 2 production, and deep body temperature were analyzed in resting animals, using an indirect calorimetry system INCA (Somedic; Sweden) and telemetry system E-Mitter (Mini Mitter Co. Inc.; USA). Transgenic mice with ectopic expression of mitochondrial uncoupling protein 1 (UCP1) in white fat (aP2-Ucp1 mice) are resistant to a high-fat (HF) diet induced obesity. Their major phenotypic features also include reduced subcutaneous fat depots, low plasma triacylglycerols and brown fat atrophy. Here we studied the mechanisms involved in the control of glucose homeostasis in the aP2-Ucp1 mice. Male transgenic and their C57BL/6J (B6) littermate controls were fed a HF diet (60% calories as fat) from 3 mo of age. The aP2-Ucp1 mice were more glucose tolerant compared to controls after 2 mo of HF feeding. Despite similar blood glucose levels, plasma insulin was lower in the transgenic than in control mice. Surprisingly, insulin-sensitizing hormone adiponectin was also lower in the transgenics, which might reflect increased expression of macrophage chemoattractant protein-1 (MCP-1) and depressed expression of PPARγ in adipose tissue of these mice. At the same time, lipid content in the skeletal muscle was decreased, while the expression of glucose transporter-4 gene was increased in the transgenic mice fed a HF diet for 2 mo. However, insulin sensitivity assessed by hyperinsulinemic-euglycemic clamps in transgenic and control mice showed a similar impairment of whole-body glucose uptake after 3 wk on HF diet. In conlusion, transgenic UCP1 protects against glucose intolerance and downregulation of Glut4 in skeletal muscle induced by a prolonged HF feeding. This effect appears to be through improvement of lipid metabolism, independent of adiponectin. Supported in part by the grant #303/03/H065 from the Grant Agency of the Czech Republic.
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The expression of eotaxin mRNA in 3T3-L1 is upregulated during the process of differentiatin Studies of eotaxin, in the relationship with obesity, have been reported recently. Hashimoto group reported that serum eotaxin levels are correlated with BMI. Vasudevan group also investigated that serum eotaxin levels were higher in adipose tissue of obese compared to that of lean subjects. Furthermore, we also reported that the expression of eotaxin mRNA are increased in TNF-alpha-treated human SGBS adipocyte using DNA microarray. We assumed that eotaxin may be a critical molecule that links obesity and inflammation. We investigated the expression levels of eotaxin mRNA during 3T3-L1 adipocytes differentiation as well as in ob/ob mice and of LPS-treated 3T3-L1 adipocytes by real-time RT-PCR. To examine the expression levels of eotaxin in 3T3-L1 adipocyte during differentiation, 3T3-L1 adipocytes were collected from days 2 to 12 after the induction of differentiation. The expression levels of eotaxin mRNA are increased from 1.5-folds to 80-folds to that of D-2, respectively. The expression level of eotaxin mRNA in ob/ob mice was increased more than 4-folds in comparison with lean mice. We also examined the expression level of eotaxin mRNA in 100ng/ml LPS-treated 3T3-L1 adipocyte. We expected the increased level of eotaxin by LPS treatment, but, to our surprise, its expression is decreased 40%. Our other results are well corresponds with the data of other groups. However, in our previous study, mRNA level of eotaxin was increased in TNF-alpha-treated human SGBS cells. Therefore, we need to study further about the effect of pro-inflammatory drugs on 3T3-L1 adipocytes.
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Role of beta-endorphin in obesity
Handjieva-Darlenska Theodora 1 , Handjiev Svetoslav 2 1 Medical Faculty-Sofia, Medical University-Sofia, Bulgaria; 2 National Multiprofile Transport Hospital "Tsar Boris III", Sofia, Bulgaria Biocorect+ is six different products, containing propolis, multi-flavour honey, bee pollen, different Bulgarian herbs and lot of biological active substances. The products are designed for obese persons, who beside the overweight suffered from arterial hypertension, dislipidemia, arthrosis, holelithiasis and persons who are exposed to psycho-emotional stress. The aim of this study was to investigate the possible positive effect of Biocorect + on different metabolic and blood parameters in obese subjects. 446 persons (200 males and 246 females) were examined. The mean age was 40, 3 years and mean body mass index (BMI) -35, 2 kg/m². After allergy examination the food (Biocorect+) was prescribed as follows: 5 days-3 x 40 drops 15 minutes before eating; 2 days 2x 60 drops (at 10 a.m. and 4p.m. in a cup of tea). At the beginning, at the end of first and second month anthropometric indexes and blood parameters (blood sugar, serum lipids and atherogenic index) were examined. After two months a significant reduction of mean weight and waist circumference was observed (mean weight-8 kg, waist circumference-8 sm., P<0, 09). Lean body mass/fat mass ratio was increased 1, 35 times (P<0, 09). At the end of the treatment the improvement of the psychotonus was detected. The decrease of plasma lipids, atherogenic index and glucose was determined. The results demonstrate that Biocorect+ exhibits a favorite healing effect in obese subjects. In addition Biocorect+ has the capacity to reduce the hyperglycemia, hypertriglyceridemia and high blood glucose. Moreover, the product did not present side effects in the patients.
